NAME	ORIGINAL SIZE	AFTER RESTRICTING TO DATASET	STATUS	
BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP	12		Rejected!	
BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN	9		Rejected!	
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP	295	108		
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN	37	21		
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP	41	27		
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN	118	81		
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP	204	133		
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	122	54		
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP	285	179		
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	119	53		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	86	33		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN	77	49		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP	338	183		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN	24		Rejected!	
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	174	82		
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN	14		Rejected!	
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	542	284		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN	96	61		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP	483	238		
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN	76	56		
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	144	90		
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	58	33		
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP	378	255		
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN	216	116		
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	136	84		
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN	81	44		
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP	644	434		
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	187	148		
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	172	66		
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	175	150		
BUFFA_HYPOXIA_METAGENE	50	49		
NAKAMURA_CANCER_MICROENVIRONMENT_UP	28	15		
NAKAMURA_CANCER_MICROENVIRONMENT_DN	46	41		
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	22	17		
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	20		Rejected!	
WINTER_HYPOXIA_UP	95	80		
WINTER_HYPOXIA_DN	52	25		
PARENT_MTOR_SIGNALING_UP	568	463		
PARENT_MTOR_SIGNALING_DN	44	27		
PYEON_HPV_POSITIVE_TUMORS_UP	99	64		
PYEON_HPV_POSITIVE_TUMORS_DN	10		Rejected!	
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	284	232		
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	644	486		
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	211	153		
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	137	120		
LU_TUMOR_VASCULATURE_UP	29	15		
LU_TUMOR_VASCULATURE_DN	13		Rejected!	
KORKOLA_EMBRYONAL_CARCINOMA_UP	42	35		
KORKOLA_EMBRYONAL_CARCINOMA_DN	13		Rejected!	
KORKOLA_TERATOMA_UP	17	15		
KORKOLA_YOLK_SAC_TUMOR_UP	20	18		
KORKOLA_CHORIOCARCINOMA_UP	6		Rejected!	
KORKOLA_CHORIOCARCINOMA_DN	11		Rejected!	
KORKOLA_SEMINOMA_UP	44	37		
KORKOLA_SEMINOMA_DN	13		Rejected!	
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	113	98		
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	93	81		
HOLLMANN_APOPTOSIS_VIA_CD40_UP	203	162		
HOLLMANN_APOPTOSIS_VIA_CD40_DN	267	197		
LIU_PROSTATE_CANCER_UP	98	78		
LIU_PROSTATE_CANCER_DN	491	297		
LIU_SOX4_TARGETS_UP	139	120		
LIU_SOX4_TARGETS_DN	310	276		
ONKEN_UVEAL_MELANOMA_UP	790		Rejected!	
ONKEN_UVEAL_MELANOMA_DN	529	420		
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	206	158		
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	180	121		
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	352	231		
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	85	63		
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	60	41		
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	20		Rejected!	
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	20	15		
FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN	6		Rejected!	
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	11		Rejected!	
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	22	20		
NAM_FXYD5_TARGETS_DN	18	17		
FRASOR_TAMOXIFEN_RESPONSE_UP	51	44		
FRASOR_TAMOXIFEN_RESPONSE_DN	12		Rejected!	
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	136	68		
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	10		Rejected!	
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	302	250		
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	358	142		
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	29	17		
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	69	35		
KOBAYASHI_EGFR_SIGNALING_6HR_UP	7		Rejected!	
KOBAYASHI_EGFR_SIGNALING_6HR_DN	18	17		
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	154	146		
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	53	37		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	26	21		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	467	327		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	30	25		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	39	31		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	39	27		
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	66	51		
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	147	120		
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	402	267		
ZERBINI_RESPONSE_TO_SULINDAC_UP	9		Rejected!	
ZERBINI_RESPONSE_TO_SULINDAC_DN	6		Rejected!	
IGARASHI_ATF4_TARGETS_UP	5		Rejected!	
IGARASHI_ATF4_TARGETS_DN	98	75		
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	187	112		
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	71	61		
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	339	244		
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	179	125		
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	258	189		
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	66	35		
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	64	44		
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	14		Rejected!	
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	402	269		
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	174	67		
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	66	49		
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN	7		Rejected!	
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	46	34		
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	202	122		
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	73	60		
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	70	38		
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	23		Rejected!	
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN	7		Rejected!	
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	70	51		
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	91	56		
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	96	61		
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	74	51		
CHANDRAN_METASTASIS_TOP50_UP	37	31		
CHANDRAN_METASTASIS_TOP50_DN	44	37		
WILCOX_RESPONSE_TO_PROGESTERONE_UP	153	112		
WILCOX_RESPONSE_TO_PROGESTERONE_DN	62	42		
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	585	451		
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	454	330		
GARY_CD5_TARGETS_UP	473	391		
GARY_CD5_TARGETS_DN	440	395		
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	449	246		
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	377	253		
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP	8		Rejected!	
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	59	38		
HOOI_ST7_TARGETS_UP	92	57		
HOOI_ST7_TARGETS_DN	117	68		
PRAMOONJAGO_SOX4_TARGETS_UP	52	50		
PRAMOONJAGO_SOX4_TARGETS_DN	49	42		
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	79	64		
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	146	128		
PIEPOLI_LGI1_TARGETS_UP	17		Rejected!	
PIEPOLI_LGI1_TARGETS_DN	17		Rejected!	
THUM_SYSTOLIC_HEART_FAILURE_UP	429	310		
THUM_SYSTOLIC_HEART_FAILURE_DN	206	131		
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	173	113		
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	669		Rejected!	
CORRE_MULTIPLE_MYELOMA_UP	77	36		
CORRE_MULTIPLE_MYELOMA_DN	58	39		
HUTTMANN_B_CLL_POOR_SURVIVAL_UP	285	192		
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	59	36		
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	1399		Rejected!	
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	117	73		
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	39	29		
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	367	258		
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	324	230		
LIU_CMYB_TARGETS_UP	164	139		
LIU_CMYB_TARGETS_DN	6		Rejected!	
LIU_VMYB_TARGETS_UP	125	104		
LIU_TARGETS_OF_VMYB_VS_CMYB_UP	15		Rejected!	
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	44	18		
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	385	295		
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	455	348		
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	453	364		
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	465	349		
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	125	109		
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	52	33		
DOANE_BREAST_CANCER_CLASSES_UP	71	40		
DOANE_BREAST_CANCER_CLASSES_DN	33	25		
DOANE_RESPONSE_TO_ANDROGEN_UP	184	117		
DOANE_RESPONSE_TO_ANDROGEN_DN	242	191		
DOANE_BREAST_CANCER_ESR1_UP	111	64		
DOANE_BREAST_CANCER_ESR1_DN	47	23		
WANG_RESPONSE_TO_ANDROGEN_UP	28	24		
WANG_RESPONSE_TO_FORSKOLIN_UP	22	17		
WANG_RESPONSE_TO_FORSKOLIN_DN	9		Rejected!	
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16		Rejected!	
LAIHO_COLORECTAL_CANCER_SERRATED_UP	115	104		
LAIHO_COLORECTAL_CANCER_SERRATED_DN	86	69		
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	311	291		
BORCZUK_MALIGNANT_MESOTHELIOMA_DN	105	39		
ROY_WOUND_BLOOD_VESSEL_UP	50	36		
ROY_WOUND_BLOOD_VESSEL_DN	23	17		
GRABARCZYK_BCL11B_TARGETS_UP	81	63		
GRABARCZYK_BCL11B_TARGETS_DN	60	39		
NEWMAN_ERCC6_TARGETS_UP	26	20		
NEWMAN_ERCC6_TARGETS_DN	39	15		
HORIUCHI_WTAP_TARGETS_UP	308	218		
HORIUCHI_WTAP_TARGETS_DN	317	281		
GAL_LEUKEMIC_STEM_CELL_UP	128	88		
GAL_LEUKEMIC_STEM_CELL_DN	235	145		
CHOI_ATL_CHRONIC_VS_ACUTE_DN	19	18		
BASAKI_YBX1_TARGETS_UP	292	252		
BASAKI_YBX1_TARGETS_DN	392	308		
NOJIMA_SFRP2_TARGETS_UP	32	21		
NOJIMA_SFRP2_TARGETS_DN	26	21		
WIKMAN_ASBESTOS_LUNG_CANCER_UP	17		Rejected!	
WIKMAN_ASBESTOS_LUNG_CANCER_DN	30	23		
RODRIGUES_DCC_TARGETS_UP	6		Rejected!	
RODRIGUES_DCC_TARGETS_DN	119	99		
RODRIGUES_NTN1_TARGETS_UP	17		Rejected!	
RODRIGUES_NTN1_TARGETS_DN	160	123		
WANG_LMO4_TARGETS_UP	364	289		
WANG_LMO4_TARGETS_DN	357	309		
WANG_CLIM2_TARGETS_UP	261	173		
WANG_CLIM2_TARGETS_DN	181	155		
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	176	96		
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	145	98		
VECCHI_GASTRIC_CANCER_EARLY_UP	434	358		
VECCHI_GASTRIC_CANCER_EARLY_DN	380	144		
BARRIER_COLON_CANCER_RECURRENCE_UP	42	36		
BARRIER_COLON_CANCER_RECURRENCE_DN	19	16		
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	159	113		
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN	5		Rejected!	
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	79	50		
JAEGER_METASTASIS_UP	46	34		
JAEGER_METASTASIS_DN	258	163		
OSMAN_BLADDER_CANCER_UP	398	348		
OSMAN_BLADDER_CANCER_DN	423	327		
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	68	58		
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	333	264		
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	109	86		
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	184	155		
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	221	167		
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	280	210		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	32	30		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	23	21		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	83	72		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	56	45		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	26	18		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	28	23		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	12		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	11		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	26	22		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	24	19		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	139	115		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	62	48		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	35	28		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	11		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	19		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	79	48		
RUNNE_GENDER_EFFECT_UP	9		Rejected!	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	86	44		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	44	30		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	183	105		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	30	16		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	156	80		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	204	104		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	194	107		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	150	79		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	177	91		
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	127	73		
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	14		Rejected!	
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN	7		Rejected!	
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	31	16		
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	33	25		
BILBAN_B_CLL_LPL_UP	64	46		
BILBAN_B_CLL_LPL_DN	42	33		
HOEBEKE_LYMPHOID_STEM_CELL_UP	97	70		
HOEBEKE_LYMPHOID_STEM_CELL_DN	88	74		
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	32	19		
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	22		Rejected!	
AKL_HTLV1_INFECTION_UP	27	25		
AKL_HTLV1_INFECTION_DN	69	49		
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	76	56		
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	368	328		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	262	186		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	125	93		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	129	96		
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	76	57		
MULLIGHAN_MLL_SIGNATURE_1_UP	384	295		
MULLIGHAN_MLL_SIGNATURE_1_DN	238	157		
MULLIGHAN_MLL_SIGNATURE_2_UP	420	328		
MULLIGHAN_MLL_SIGNATURE_2_DN	278	198		
MULLIGHAN_NPM1_SIGNATURE_3_UP	332	243		
MULLIGHAN_NPM1_SIGNATURE_3_DN	161	119		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	15		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN	7		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	184	128		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	193	120		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	54	35		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	18		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	203	164		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	56	30		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	159	100		
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	18		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	21		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN	10		Rejected!	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	44	30		
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	14		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN	7		Rejected!	
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	53	44		
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	42	29		
DITTMER_PTHLH_TARGETS_UP	113	107		
DITTMER_PTHLH_TARGETS_DN	70	59		
UDAYAKUMAR_MED1_TARGETS_UP	135	125		
UDAYAKUMAR_MED1_TARGETS_DN	244	201		
ODONNELL_TFRC_TARGETS_UP	427	199		
ODONNELL_TFRC_TARGETS_DN	137	96		
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	82	51		
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	47	41		
SENESE_HDAC1_TARGETS_UP	451	349		
SENESE_HDAC1_TARGETS_DN	266	167		
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	243	152		
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	238	138		
SENESE_HDAC2_TARGETS_UP	116	88		
SENESE_HDAC2_TARGETS_DN	133	75		
SENESE_HDAC3_TARGETS_UP	494	373		
SENESE_HDAC3_TARGETS_DN	547	415		
LEE_NEURAL_CREST_STEM_CELL_UP	147	73		
LEE_NEURAL_CREST_STEM_CELL_DN	122	69		
HUMMEL_BURKITTS_LYMPHOMA_UP	43	27		
HUMMEL_BURKITTS_LYMPHOMA_DN	15		Rejected!	
TIEN_INTESTINE_PROBIOTICS_2HR_UP	30	27		
TIEN_INTESTINE_PROBIOTICS_2HR_DN	89	84		
TIEN_INTESTINE_PROBIOTICS_6HR_UP	53	49		
TIEN_INTESTINE_PROBIOTICS_6HR_DN	170	158		
TIEN_INTESTINE_PROBIOTICS_24HR_UP	561		Rejected!	
TIEN_INTESTINE_PROBIOTICS_24HR_DN	215	199		
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	515	249		
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	278	176		
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	406	204		
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	1289		Rejected!	
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	333	239		
SABATES_COLORECTAL_ADENOMA_SIZE_UP	23		Rejected!	
SABATES_COLORECTAL_ADENOMA_SIZE_DN	13		Rejected!	
SABATES_COLORECTAL_ADENOMA_UP	140	78		
SABATES_COLORECTAL_ADENOMA_DN	299	129		
SCIBETTA_KDM5B_TARGETS_UP	19	16		
SCIBETTA_KDM5B_TARGETS_DN	79	70		
NAGASHIMA_NRG1_SIGNALING_UP	172	144		
NAGASHIMA_NRG1_SIGNALING_DN	54	34		
NAGASHIMA_EGF_SIGNALING_UP	57	50		
KIM_WT1_TARGETS_UP	217	181		
KIM_WT1_TARGETS_DN	471	401		
KIM_WT1_TARGETS_8HR_UP	167	140		
KIM_WT1_TARGETS_8HR_DN	125	78		
KIM_WT1_TARGETS_12HR_UP	166	129		
KIM_WT1_TARGETS_12HR_DN	216	172		
ELVIDGE_HYPOXIA_UP	172	129		
ELVIDGE_HYPOXIA_DN	147	129		
ELVIDGE_HYPOXIA_BY_DMOG_UP	133	99		
ELVIDGE_HYPOXIA_BY_DMOG_DN	59	46		
ELVIDGE_HIF1A_TARGETS_UP	67	56		
ELVIDGE_HIF1A_TARGETS_DN	92	67		
ELVIDGE_HIF2A_TARGETS_UP	6		Rejected!	
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	41	34		
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	105	77		
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	321	205		
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	235	110		
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	20		Rejected!	
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	12		Rejected!	
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	24	15		
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	11		Rejected!	
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	94	67		
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	46	26		
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	59	37		
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	12		Rejected!	
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	13		Rejected!	
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN	10		Rejected!	
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	184	156		
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	94	59		
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	64	43		
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	89	78		
BIDUS_METASTASIS_UP	219	191		
BIDUS_METASTASIS_DN	154	118		
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	270	250		
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	198	141		
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	140	131		
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	71	45		
MAYBURD_RESPONSE_TO_L663536_UP	31	23		
MAYBURD_RESPONSE_TO_L663536_DN	56	45		
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	19	15		
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	15		Rejected!	
DODD_NASOPHARYNGEAL_CARCINOMA_UP	1806		Rejected!	
DODD_NASOPHARYNGEAL_CARCINOMA_DN	1402		Rejected!	
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	640		Rejected!	
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	784		Rejected!	
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	721		Rejected!	
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	529	374		
RODRIGUES_THYROID_CARCINOMA_UP	16	15		
RODRIGUES_THYROID_CARCINOMA_DN	77	61		
GOZGIT_ESR1_TARGETS_UP	149	96		
GOZGIT_ESR1_TARGETS_DN	777	458		
HAHTOLA_SEZARY_SYNDROM_UP	99	70		
HAHTOLA_SEZARY_SYNDROM_DN	44		Rejected!	
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	176	149		
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	27	25		
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	63	47		
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	115	103		
HAHTOLA_MYCOSIS_FUNGOIDES_UP	18		Rejected!	
HAHTOLA_MYCOSIS_FUNGOIDES_DN	17		Rejected!	
PROVENZANI_METASTASIS_UP	204	164		
PROVENZANI_METASTASIS_DN	142	119		
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	36	25		
LIU_CDX2_TARGETS_UP	35	22		
LIU_CDX2_TARGETS_DN	8		Rejected!	
COLDREN_GEFITINIB_RESISTANCE_UP	86	71		
COLDREN_GEFITINIB_RESISTANCE_DN	228	188		
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	130	115		
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	61	53		
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	118	98		
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	72	69		
PASTURAL_RIZ1_TARGETS_UP	10		Rejected!	
PASTURAL_RIZ1_TARGETS_DN	5		Rejected!	
CHOW_RASSF1_TARGETS_UP	26	23		
CHOW_RASSF1_TARGETS_DN	30	29		
ENK_UV_RESPONSE_EPIDERMIS_UP	296	240		
ENK_UV_RESPONSE_EPIDERMIS_DN	513	417		
ENK_UV_RESPONSE_KERATINOCYTE_UP	534	438		
ENK_UV_RESPONSE_KERATINOCYTE_DN	481	429		
LANDIS_BREAST_CANCER_PROGRESSION_UP	46	42		
LANDIS_BREAST_CANCER_PROGRESSION_DN	72	60		
GESERICK_TERT_TARGETS_DN	21	19		
YEMELYANOV_GR_TARGETS_DN	11		Rejected!	
LAU_APOPTOSIS_CDKN2A_UP	55	53		
LAU_APOPTOSIS_CDKN2A_DN	5		Rejected!	
DELYS_THYROID_CANCER_UP	445	314		
DELYS_THYROID_CANCER_DN	233	120		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	59	52		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	54	46		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	132	122		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	141	123		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	123	105		
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	151	134		
CASTELLANO_HRAS_TARGETS_DN	6		Rejected!	
CASTELLANO_HRAS_AND_NRAS_TARGETS_UP	6		Rejected!	
CASTELLANO_HRAS_AND_NRAS_TARGETS_DN	8		Rejected!	
CASTELLANO_NRAS_TARGETS_UP	72	55		
CASTELLANO_NRAS_TARGETS_DN	14		Rejected!	
CHEBOTAEV_GR_TARGETS_UP	78	52		
CHEBOTAEV_GR_TARGETS_DN	123	66		
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	28	20		
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	48	46		
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP	10		Rejected!	
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	30	27		
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	120	97		
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	378	316		
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP	8		Rejected!	
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	141	110		
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	327	277		
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	226	172		
KOINUMA_COLON_CANCER_MSI_UP	16		Rejected!	
KOINUMA_COLON_CANCER_MSI_DN	8		Rejected!	
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	34	33		
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	23	23		
NADERI_BREAST_CANCER_PROGNOSIS_UP	51	35		
NADERI_BREAST_CANCER_PROGNOSIS_DN	18		Rejected!	
MARKEY_RB1_CHRONIC_LOF_UP	112	95		
MARKEY_RB1_CHRONIC_LOF_DN	123	95		
MARKEY_RB1_ACUTE_LOF_UP	237	215		
MARKEY_RB1_ACUTE_LOF_DN	229	196		
CHIN_BREAST_CANCER_COPY_NUMBER_UP	28	21		
CHIN_BREAST_CANCER_COPY_NUMBER_DN	13		Rejected!	
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	563	444		
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	235	180		
VANHARANTA_UTERINE_FIBROID_UP	44	29		
VANHARANTA_UTERINE_FIBROID_DN	67	54		
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	66	57		
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	36	32		
LANDIS_ERBB2_BREAST_TUMORS_65_UP	22	19		
LANDIS_ERBB2_BREAST_TUMORS_65_DN	39	33		
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	19	18		
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	57	49		
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	238	189		
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	176	127		
ODONNELL_METASTASIS_UP	75	29		
ODONNELL_METASTASIS_DN	24	17		
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	218	163		
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	84	68		
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	1151		Rejected!	
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	1769		Rejected!	
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	611		Rejected!	
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	771		Rejected!	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	193	150		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	95	56		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	27	15		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN	8		Rejected!	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	172	129		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	21		Rejected!	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	38	20		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN	9		Rejected!	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	97	60		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	22		Rejected!	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	182	127		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	37	21		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	247	142		
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	35	24		
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	21	20		
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	30	26		
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	22	21		
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN	13		Rejected!	
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	118	109		
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	12		Rejected!	
LANDIS_ERBB2_BREAST_TUMORS_324_UP	151	138		
LANDIS_ERBB2_BREAST_TUMORS_324_DN	152	130		
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	33	25		
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	31	26		
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16	15		
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	12		Rejected!	
BARIS_THYROID_CANCER_UP	24	20		
BARIS_THYROID_CANCER_DN	59	54		
BERENJENO_TRANSFORMED_BY_RHOA_UP	550		Rejected!	
BERENJENO_TRANSFORMED_BY_RHOA_DN	398	333		
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP	7		Rejected!	
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	29		Rejected!	
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	26	19		
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	37	27		
KERLEY_RESPONSE_TO_CISPLATIN_UP	45	34		
KERLEY_RESPONSE_TO_CISPLATIN_DN	5		Rejected!	
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	125	97		
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	122	110		
TANG_SENESCENCE_TP53_TARGETS_UP	33	18		
TANG_SENESCENCE_TP53_TARGETS_DN	56	46		
WANG_BARRETTS_ESOPHAGUS_UP	52	37		
WANG_BARRETTS_ESOPHAGUS_DN	25	21		
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	121	96		
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	101	88		
WANG_ESOPHAGUS_CANCER_PROGRESSION_UP	9		Rejected!	
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15		Rejected!	
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	18		Rejected!	
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	63	41		
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	26		Rejected!	
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	57	56		
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	22		Rejected!	
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	211	166		
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	40	33		
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	270	214		
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	199	161		
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	123	103		
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	131	109		
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	193	162		
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	80	69		
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	16		Rejected!	
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	16		Rejected!	
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	53	28		
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	19		Rejected!	
LUI_THYROID_CANCER_PAX8_PPARG_UP	46	35		
LUI_THYROID_CANCER_PAX8_PPARG_DN	46	42		
HAMAI_APOPTOSIS_VIA_TRAIL_UP	655		Rejected!	
HAMAI_APOPTOSIS_VIA_TRAIL_DN	202	110		
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	69	62		
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	36		Rejected!	
HUMMERICH_BENIGN_SKIN_TUMOR_UP	17		Rejected!	
HUMMERICH_BENIGN_SKIN_TUMOR_DN	19		Rejected!	
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	168	156		
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	63	50		
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP	18	17		
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	20		Rejected!	
LUCAS_HNF4A_TARGETS_UP	58	47		
LUCAS_HNF4A_TARGETS_DN	8		Rejected!	
ZIRN_TRETINOIN_RESPONSE_WT1_UP	23		Rejected!	
ZIRN_TRETINOIN_RESPONSE_WT1_DN	6		Rejected!	
ZIRN_TRETINOIN_RESPONSE_UP	20		Rejected!	
ZIRN_TRETINOIN_RESPONSE_DN	6		Rejected!	
STREICHER_LSM1_TARGETS_UP	44	36		
STREICHER_LSM1_TARGETS_DN	19		Rejected!	
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	123	81		
LANG_MYB_FAMILY_TARGETS	29	27		
MCBRYAN_TERMINAL_END_BUD_UP	13		Rejected!	
MCBRYAN_TERMINAL_END_BUD_DN	6		Rejected!	
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	29	28		
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	13		Rejected!	
DARWICHE_SKIN_TUMOR_PROMOTER_UP	143	100		
DARWICHE_SKIN_TUMOR_PROMOTER_DN	187	130		
DARWICHE_PAPILLOMA_RISK_LOW_UP	163	112		
DARWICHE_PAPILLOMA_RISK_LOW_DN	168	118		
DARWICHE_PAPILLOMA_RISK_HIGH_UP	150	106		
DARWICHE_PAPILLOMA_RISK_HIGH_DN	180	124		
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	150	111		
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	180	119		
MAHADEVAN_IMATINIB_RESISTANCE_UP	22		Rejected!	
MAHADEVAN_IMATINIB_RESISTANCE_DN	20		Rejected!	
TOMIDA_METASTASIS_UP	26	20		
TOMIDA_METASTASIS_DN	18		Rejected!	
SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN	13		Rejected!	
OZANNE_AP1_TARGETS_UP	14		Rejected!	
HWANG_PROSTATE_CANCER_MARKERS	28	23		
HU_ANGIOGENESIS_UP	21	15		
HU_ANGIOGENESIS_DN	37	32		
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	59	39		
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	46	39		
DARWICHE_PAPILLOMA_PROGRESSION_RISK	77	39		
SHIRAISHI_PLZF_TARGETS_UP	10		Rejected!	
SHIRAISHI_PLZF_TARGETS_DN	9		Rejected!	
MOTAMED_RESPONSE_TO_ANDROGEN_UP	5		Rejected!	
MOTAMED_RESPONSE_TO_ANDROGEN_DN	6		Rejected!	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP	10		Rejected!	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN	10		Rejected!	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP	6		Rejected!	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN	8		Rejected!	
OLSSON_E2F3_TARGETS_UP	25	20		
OLSSON_E2F3_TARGETS_DN	39	29		
MARKS_HDAC_TARGETS_UP	23	18		
MARKS_HDAC_TARGETS_DN	15		Rejected!	
CHOI_ATL_ACUTE_STAGE	6		Rejected!	
CHOI_ATL_STAGE_PREDICTOR	44	39		
WONG_ENDMETRIUM_CANCER_UP	25		Rejected!	
WONG_ENDMETRIUM_CANCER_DN	78	25		
WONG_ENDOMETRIAL_CANCER_LATE	9		Rejected!	
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	13		Rejected!	
KONG_E2F1_TARGETS	11		Rejected!	
KONG_E2F3_TARGETS	97	89		
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	102	49		
EGUCHI_CELL_CYCLE_RB1_TARGETS	22	22		
CROSBY_E2F4_TARGETS	6		Rejected!	
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	12		Rejected!	
IVANOV_MUTATED_IN_COLON_CANCER	13		Rejected!	
TAKAYAMA_BOUND_BY_AR	10		Rejected!	
RIZ_ERYTHROID_DIFFERENTIATION	82	72		
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	43	37		
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	37	24		
CHASSOT_SKIN_WOUND	9		Rejected!	
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	186	159		
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	800		Rejected!	
MUELLER_METHYLATED_IN_GLIOBLASTOMA	43	21		
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	26	15		
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	25		Rejected!	
RIZ_ERYTHROID_DIFFERENTIATION_6HR	38	16		
RIZ_ERYTHROID_DIFFERENTIATION_12HR	37	23		
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	199	114		
PEREZ_TP53_TARGETS	1195		Rejected!	
PEREZ_TP63_TARGETS	355	198		
PEREZ_TP53_AND_TP63_TARGETS	208	125		
WAKASUGI_HAVE_ZNF143_BINDING_SITES	54	49		
RODRIGUES_NTN1_AND_DCC_TARGETS	34	23		
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	25	23		
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	85	75		
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	59	50		
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	84	71		
TURJANSKI_MAPK1_AND_MAPK2_TARGETS	12		Rejected!	
TURJANSKI_MAPK8_AND_MAPK9_TARGETS	8		Rejected!	
TURJANSKI_MAPK7_TARGETS	7		Rejected!	
TURJANSKI_MAPK11_TARGETS	5		Rejected!	
TURJANSKI_MAPK14_TARGETS	10		Rejected!	
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	15		Rejected!	
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	38	29		
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	51	43		
NAGY_TFTC_COMPONENTS_HUMAN	18	17		
NAGY_STAGA_COMPONENTS_HUMAN	13		Rejected!	
NAGY_PCAF_COMPONENTS_HUMAN	9		Rejected!	
BAKER_HEMATOPOESIS_STAT1_TARGETS	10		Rejected!	
BAKER_HEMATOPOIESIS_STAT3_TARGETS	15		Rejected!	
BAKER_HEMATOPOESIS_STAT5_TARGETS	7		Rejected!	
SEIDEN_MET_SIGNALING	20	20		
AUNG_GASTRIC_CANCER	52	40		
SANCHEZ_MDM2_TARGETS	15		Rejected!	
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	15		Rejected!	
NAKAMURA_LUNG_CANCER	9		Rejected!	
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	41	38		
HAEGERSTRAND_RESPONSE_TO_IMATINIB	9		Rejected!	
MATHEW_FANCONI_ANEMIA_GENES	11		Rejected!	
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	55	41		
GILMORE_CORE_NFKB_PATHWAY	13		Rejected!	
SCHEIDEREIT_IKK_TARGETS	18	16		
DUTTA_APOPTOSIS_VIA_NFKB	33	27		
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	21		Rejected!	
ROVERSI_GLIOMA_COPY_NUMBER_DN	54	29		
SEIDEN_ONCOGENESIS_BY_MET	89	81		
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	87	76		
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	102	88		
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	32	18		
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	45	22		
ROVERSI_GLIOMA_LOH_REGIONS	45	23		
ROVERSI_GLIOMA_COPY_NUMBER_UP	99	63		
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	39	31		
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	124	115		
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	46	38		
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	49	38		
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	133	103		
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	87	66		
RASHI_NFKB1_TARGETS	19	19		
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	24	22		
AIGNER_ZEB1_TARGETS	35	32		
SUZUKI_AMPLIFIED_IN_ORAL_CANCER	17		Rejected!	
HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3	8		Rejected!	
MARTIN_INTERACT_WITH_HDAC	40	33		
LASTOWSKA_COAMPLIFIED_WITH_MYCN	43	26		
IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM	6		Rejected!	
LI_LUNG_CANCER	41	35		
LI_AMPLIFIED_IN_LUNG_CANCER	183	159		
LINDGREN_BLADDER_CANCER_CLUSTER_2B	389	267		
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	49	43		
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	116	100		
NAKAMURA_ALVEOLAR_EPITHELIUM	5		Rejected!	
NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA	7		Rejected!	
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS	13		Rejected!	
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	14		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	19	15		
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24	14		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25	9		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7	7		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27	10		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15	10		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29	8		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9	8		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16	9		Rejected!	
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	49	30		
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	48	25		
SCHAVOLT_TARGETS_OF_TP53_AND_TP63	15		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8	12		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	19		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2	5		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30	5		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12	11		Rejected!	
MATTIOLI_MGUS_VS_PCL	127	94		
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	17		Rejected!	
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	327	241		
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	329	248		
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	329	248		
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5	5		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18	5		Rejected!	
LUI_THYROID_CANCER_CLUSTER_1	52	40		
LUI_THYROID_CANCER_CLUSTER_2	43	32		
LUI_THYROID_CANCER_CLUSTER_3	28	24		
LUI_THYROID_CANCER_CLUSTER_4	21		Rejected!	
LUI_THYROID_CANCER_CLUSTER_5	16		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22	11		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1	6		Rejected!	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13	6		Rejected!	
GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	14		Rejected!	
LUI_TARGETS_OF_PAX8_PPARG_FUSION	34	29		
SCHLOSSER_SERUM_RESPONSE_UP	127	88		
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	107	92		
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	33	33		
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	162	149		
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	48	48		
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	48	46		
SCHLOSSER_SERUM_RESPONSE_DN	703		Rejected!	
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	17		Rejected!	
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	37	28		
FARMER_BREAST_CANCER_CLUSTER_1	48	24		
FARMER_BREAST_CANCER_CLUSTER_8	6		Rejected!	
FARMER_BREAST_CANCER_CLUSTER_7	20	15		
FARMER_BREAST_CANCER_CLUSTER_2	33	33		
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	140	136		
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	53	48		
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	40	36		
HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER	13		Rejected!	
HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER	7		Rejected!	
OHASHI_AURKA_TARGETS	5		Rejected!	
OHASHI_AURKB_TARGETS	8		Rejected!	
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	19		Rejected!	
LA_MEN1_TARGETS	25	19		
KOMMAGANI_TP63_GAMMA_TARGETS	9		Rejected!	
LUND_SILENCED_BY_METHYLATION	15		Rejected!	
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	16	15		
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	17	15		
BOWIE_RESPONSE_TO_TAMOXIFEN	18	15		
AIYAR_COBRA1_TARGETS_UP	40	31		
AIYAR_COBRA1_TARGETS_DN	29	28		
LI_CISPLATIN_RESISTANCE_DN	33	18		
LI_CISPLATIN_RESISTANCE_UP	26		Rejected!	
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	23		Rejected!	
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN	6		Rejected!	
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	35	17		
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	37	28		
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	71	44		
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	22		Rejected!	
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	61	42		
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	18		Rejected!	
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	25	20		
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	19	17		
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	35	26		
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	19	15		
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	13		Rejected!	
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	23	16		
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP	10		Rejected!	
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	88	39		
XU_AKT1_TARGETS_6HR	27	21		
XU_AKT1_TARGETS_48HR	9		Rejected!	
SHI_SPARC_TARGETS_UP	24	18		
SHI_SPARC_TARGETS_DN	13		Rejected!	
WAESCH_ANAPHASE_PROMOTING_COMPLEX	13		Rejected!	
AGARWAL_AKT_PATHWAY_TARGETS	11		Rejected!	
NEBEN_AML_WITH_FLT3_OR_NRAS_UP	8		Rejected!	
NEBEN_AML_WITH_FLT3_OR_NRAS_DN	12		Rejected!	
DIRMEIER_LMP1_RESPONSE_EARLY	62	48		
EINAV_INTERFERON_SIGNATURE_IN_CANCER	27	21		
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	16		Rejected!	
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	37	29		
NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF	8		Rejected!	
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	20		Rejected!	
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3	7		Rejected!	
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	46	25		
DAUER_STAT3_TARGETS_UP	48	40		
DAUER_STAT3_TARGETS_DN	48	38		
PATIL_LIVER_CANCER	659		Rejected!	
KORKOLA_EMBRYONAL_CARCINOMA	11		Rejected!	
KORKOLA_TERATOMA	42	32		
KORKOLA_YOLK_SAC_TUMOR	65	31		
KORKOLA_CHORIOCARCINOMA	7		Rejected!	
WANG_METHYLATED_IN_BREAST_CANCER	35	30		
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	57	45		
TERAMOTO_OPN_TARGETS_CLUSTER_1	15		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_3	7		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_4	15		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_5	7		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_6	26	21		
TERAMOTO_OPN_TARGETS_CLUSTER_7	18		Rejected!	
TERAMOTO_OPN_TARGETS_CLUSTER_8	8		Rejected!	
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	75	52		
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	32	22		
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	72	43		
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	22	18		
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	12		Rejected!	
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	19	19		
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	28		Rejected!	
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	34	22		
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	14		Rejected!	
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN	9		Rejected!	
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	316	271		
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	856		Rejected!	
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	466	425		
DIRMEIER_LMP1_RESPONSE_LATE_UP	56	48		
DIRMEIER_LMP1_RESPONSE_LATE_DN	30	24		
HEIDENBLAD_AMPLICON_8Q24_UP	41	31		
HEIDENBLAD_AMPLICON_8Q24_DN	39	33		
HEIDENBLAD_AMPLICON_12P11_12_UP	36	27		
HEIDENBLAD_AMPLICON_12P11_12_DN	25	17		
AMUNDSON_RESPONSE_TO_ARSENITE	219	183		
FUNG_IL2_SIGNALING_2	11		Rejected!	
FUNG_IL2_SIGNALING_1	10		Rejected!	
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1	9		Rejected!	
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES	7		Rejected!	
SASAKI_TARGETS_OF_TP73_AND_TP63	12		Rejected!	
YANAGIHARA_ESX1_TARGETS	29	22		
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	26	20		
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	38	26		
TSUNODA_CISPLATIN_RESISTANCE_UP	15		Rejected!	
TSUNODA_CISPLATIN_RESISTANCE_DN	50	36		
MAINA_HYPOXIA_VHL_TARGETS_UP	6		Rejected!	
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	176	133		
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	161	70		
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	237	191		
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	517	440		
LI_WILMS_TUMOR_ANAPLASTIC_UP	17	16		
LI_WILMS_TUMOR_ANAPLASTIC_DN	5		Rejected!	
BORLAK_LIVER_CANCER_EGF_UP	54	48		
MANN_RESPONSE_TO_AMIFOSTINE_UP	19	19		
MANN_RESPONSE_TO_AMIFOSTINE_DN	9		Rejected!	
YAN_ESCAPE_FROM_ANOIKIS	23	18		
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	83	42		
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	115	64		
WOOD_EBV_EBNA1_TARGETS_UP	110	84		
WOOD_EBV_EBNA1_TARGETS_DN	48	34		
MOHANKUMAR_HOXA1_TARGETS_UP	409	340		
MOHANKUMAR_HOXA1_TARGETS_DN	173	90		
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	59	24		
MURATA_VIRULENCE_OF_H_PILORI	21	17		
WANG_HCP_PROSTATE_CANCER	106	79		
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP	7		Rejected!	
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	43	36		
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP	10		Rejected!	
MAINA_VHL_TARGETS_UP	10		Rejected!	
MAINA_VHL_TARGETS_DN	16		Rejected!	
GRUETZMANN_PANCREATIC_CANCER_UP	357	311		
GRUETZMANN_PANCREATIC_CANCER_DN	199	146		
JAZAG_TGFB1_SIGNALING_UP	106	75		
JAZAG_TGFB1_SIGNALING_DN	35	21		
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	107	66		
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	65	45		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	27	18		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	48	40		
SIMBULAN_UV_RESPONSE_NORMAL_UP	9		Rejected!	
SIMBULAN_UV_RESPONSE_NORMAL_DN	33	28		
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	31	30		
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	19	15		
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	33	28		
INAMURA_LUNG_CANCER_SCC_UP	13		Rejected!	
INAMURA_LUNG_CANCER_SCC_DN	13		Rejected!	
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP	14		Rejected!	
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	50	44		
KIM_MYC_AMPLIFICATION_TARGETS_UP	202	152		
KIM_MYC_AMPLIFICATION_TARGETS_DN	97	67		
KIM_MYCN_AMPLIFICATION_TARGETS_UP	93	56		
KIM_MYCN_AMPLIFICATION_TARGETS_DN	107	76		
KIM_MYCL1_AMPLIFICATION_TARGETS_UP	14		Rejected!	
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	19	17		
TSAI_RESPONSE_TO_IONIZING_RADIATION	150	116		
YANG_BREAST_CANCER_ESR1_UP	36	26		
YANG_BREAST_CANCER_ESR1_DN	24	16		
YANG_BREAST_CANCER_ESR1_LASER_UP	32	24		
YANG_BREAST_CANCER_ESR1_LASER_DN	47	39		
YANG_BREAST_CANCER_ESR1_BULK_UP	26	24		
YANG_BREAST_CANCER_ESR1_BULK_DN	22	16		
WANG_RESPONSE_TO_BEXAROTENE_UP	34	24		
WANG_RESPONSE_TO_BEXAROTENE_DN	30	17		
STANHILL_HRAS_TRANSFROMATION_UP	6		Rejected!	
REN_MIF_TARGETS_DN	5		Rejected!	
SEMBA_FHIT_TARGETS_UP	11		Rejected!	
SEMBA_FHIT_TARGETS_DN	10		Rejected!	
SHANK_TAL1_TARGETS_DN	10		Rejected!	
HASINA_NOL7_TARGETS_UP	13		Rejected!	
HASINA_NOL7_TARGETS_DN	13		Rejected!	
KONDO_HYPOXIA	8		Rejected!	
HOWLIN_PUBERTAL_MAMMARY_GLAND	67	47		
KREPPEL_CD99_TARGETS_DN	7		Rejected!	
HATADA_METHYLATED_IN_LUNG_CANCER_UP	370	158		
HATADA_METHYLATED_IN_LUNG_CANCER_DN	35		Rejected!	
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP	5		Rejected!	
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP	5		Rejected!	
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN	5		Rejected!	
FURUKAWA_DUSP6_TARGETS_PCI35_UP	73	36		
FURUKAWA_DUSP6_TARGETS_PCI35_DN	72	60		
KARAKAS_TGFB1_SIGNALING	18		Rejected!	
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	257	209		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	167	137		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	75	63		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	286	167		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	107	45		
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	54	44		
LIEN_BREAST_CARCINOMA_METAPLASTIC	33	21		
SCHMAHL_PDGF_SIGNALING	9		Rejected!	
TOMLINS_PROSTATE_CANCER_UP	40	35		
TOMLINS_PROSTATE_CANCER_DN	40	31		
TOMLINS_METASTASIS_UP	14		Rejected!	
TOMLINS_METASTASIS_DN	20	17		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	41	28		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	42	35		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	40	34		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	33	24		
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	13		Rejected!	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	21	15		
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	484	423		
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	589		Rejected!	
HUI_MAPK14_TARGETS_UP	20		Rejected!	
DIERICK_SEROTONIN_FUNCTION_GENES	7		Rejected!	
THEODOROU_MAMMARY_TUMORIGENESIS	31		Rejected!	
BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION	13		Rejected!	
SCHLESINGER_METHYLATED_IN_COLON_CANCER	10		Rejected!	
JIANG_CORE_DUPLICON_GENES	13		Rejected!	
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	101	97		
PUJANA_XPRSS_INT_NETWORK	168	157		
PUJANA_BRCA1_PCC_NETWORK	1626		Rejected!	
PUJANA_BRCA2_PCC_NETWORK	425	364		
PUJANA_ATM_PCC_NETWORK	1395		Rejected!	
PUJANA_CHEK2_PCC_NETWORK	761		Rejected!	
PUJANA_BRCA_CENTERED_NETWORK	118	113		
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	28		Rejected!	
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	88	39		
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS	13		Rejected!	
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS	14		Rejected!	
KHETCHOUMIAN_TRIM24_TARGETS_UP	47	42		
KHETCHOUMIAN_TRIM24_TARGETS_DN	8		Rejected!	
OHM_METHYLATED_IN_ADULT_CANCERS	27	16		
OHM_EMBRYONIC_CARCINOMA_UP	6		Rejected!	
OHM_EMBRYONIC_CARCINOMA_DN	8		Rejected!	
ALCALA_APOPTOSIS	87	70		
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	22		Rejected!	
COWLING_MYCN_TARGETS	43	22		
GROSS_HYPOXIA_VIA_HIF1A_ONLY	8		Rejected!	
FALVELLA_SMOKERS_WITH_LUNG_CANCER	81	60		
OZEN_MIR125B1_TARGETS	23	20		
GALIE_TUMOR_ANGIOGENESIS	8		Rejected!	
GALIE_TUMOR_STEMNESS_GENES	6		Rejected!	
KAUFFMANN_MELANOMA_RELAPSE_UP	61	57		
KAUFFMANN_MELANOMA_RELAPSE_DN	6		Rejected!	
WILLIAMS_ESR1_TARGETS_UP	26	19		
WILLIAMS_ESR1_TARGETS_DN	6		Rejected!	
WILLIAMS_ESR2_TARGETS_UP	29	22		
WILLIAMS_ESR2_TARGETS_DN	11		Rejected!	
GROSS_ELK3_TARGETS_UP	27	22		
GROSS_ELK3_TARGETS_DN	33	29		
GROSS_HYPOXIA_VIA_ELK3_UP	209	191		
GROSS_HYPOXIA_VIA_ELK3_DN	157	135		
GROSS_HIF1A_TARGETS_UP	7		Rejected!	
GROSS_HIF1A_TARGETS_DN	26	18		
GROSS_HYPOXIA_VIA_HIF1A_UP	77	71		
GROSS_HYPOXIA_VIA_HIF1A_DN	111	90		
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	34	28		
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	44	40		
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	143	125		
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	104	94		
NUYTTEN_NIPP1_TARGETS_UP	767		Rejected!	
NUYTTEN_NIPP1_TARGETS_DN	845		Rejected!	
NUYTTEN_EZH2_TARGETS_UP	1033		Rejected!	
NUYTTEN_EZH2_TARGETS_DN	1020		Rejected!	
INGRAM_SHH_TARGETS_UP	126	85		
INGRAM_SHH_TARGETS_DN	63	45		
MARTIN_NFKB_TARGETS_UP	44	37		
MARTIN_NFKB_TARGETS_DN	10		Rejected!	
MARTIN_VIRAL_GPCR_SIGNALING_UP	87	60		
MARTIN_VIRAL_GPCR_SIGNALING_DN	53	33		
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	821		Rejected!	
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	648		Rejected!	
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	163	139		
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	96	67		
NAKAYAMA_FRA2_TARGETS	44	35		
LOPEZ_MBD_TARGETS	954		Rejected!	
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	17		Rejected!	
ROPERO_HDAC2_TARGETS	112	62		
GOUYER_TUMOR_INVASIVENESS	9		Rejected!	
LIU_LIVER_CANCER	35	22		
LIU_BREAST_CANCER	32	19		
LIU_NASOPHARYNGEAL_CARCINOMA	72	54		
LIU_COMMON_CANCER_GENES	62	52		
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	215	183		
FREDERICK_PRKCI_TARGETS	10		Rejected!	
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	20	19		
WEI_MIR34A_TARGETS	146	115		
WEI_MYCN_TARGETS_WITH_E_BOX	790		Rejected!	
LIAO_HAVE_SOX4_BINDING_SITES	41	32		
LIAO_METASTASIS	536	410		
HASEGAWA_TUMORIGENESIS_BY_RET_C634R	8		Rejected!	
TONG_INTERACT_WITH_PTTG1	57	48		
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP	9		Rejected!	
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	22	20		
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP	11		Rejected!	
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	30	28		
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	22		Rejected!	
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	26	22		
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP	13		Rejected!	
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	16		Rejected!	
GOUYER_TATI_TARGETS_UP	10		Rejected!	
GOUYER_TATI_TARGETS_DN	17		Rejected!	
CAFFAREL_RESPONSE_TO_THC_UP	32	28		
CAFFAREL_RESPONSE_TO_THC_DN	32	26		
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	15		Rejected!	
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	12		Rejected!	
CAFFAREL_RESPONSE_TO_THC_8HR_3_UP	5		Rejected!	
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN	10		Rejected!	
CAFFAREL_RESPONSE_TO_THC_24HR_3_UP	8		Rejected!	
CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	13		Rejected!	
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	33	29		
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	56	45		
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP	5		Rejected!	
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN	8		Rejected!	
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	24	17		
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	46	29		
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	18	15		
WOTTON_RUNX_TARGETS_UP	21		Rejected!	
WOTTON_RUNX_TARGETS_DN	29	22		
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP	10		Rejected!	
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN	7		Rejected!	
FUJIWARA_PARK2_IN_LIVER_CANCER_UP	8		Rejected!	
FUJIWARA_PARK2_IN_LIVER_CANCER_DN	6		Rejected!	
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	50	36		
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	167	135		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	241	196		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	380	298		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	108	87		
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	112	70		
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	124	106		
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	16		Rejected!	
RICKMAN_METASTASIS_UP	349	245		
RICKMAN_METASTASIS_DN	262	206		
FRIDMAN_SENESCENCE_UP	77	60		
FRIDMAN_SENESCENCE_DN	13		Rejected!	
FRIDMAN_IMMORTALIZATION_DN	33	25		
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	158	119		
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	462	418		
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	111	78		
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	52	26		
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	452	321		
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	407	227		
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	14		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN	10		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP	6		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN	7		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP	11		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	33	33		
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP	11		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN	8		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP	7		Rejected!	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN	5		Rejected!	
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	21	15		
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	45	36		
KOYAMA_SEMA3B_TARGETS_UP	265	167		
KOYAMA_SEMA3B_TARGETS_DN	363	238		
RICKMAN_HEAD_AND_NECK_CANCER_A	104	37		
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3	5		Rejected!	
RICKMAN_HEAD_AND_NECK_CANCER_B	54		Rejected!	
RICKMAN_HEAD_AND_NECK_CANCER_C	116	36		
RICKMAN_HEAD_AND_NECK_CANCER_D	40		Rejected!	
RICKMAN_HEAD_AND_NECK_CANCER_E	88	31		
RICKMAN_HEAD_AND_NECK_CANCER_F	55	18		
WU_CELL_MIGRATION	183	141		
TAGHAVI_NEOPLASTIC_TRANSFORMATION	11		Rejected!	
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	34	24		
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	28	21		
BALDWIN_PRKCI_TARGETS_UP	40	33		
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	70	62		
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	207	190		
HE_PTEN_TARGETS_UP	17	15		
HE_PTEN_TARGETS_DN	7		Rejected!	
AMIT_DELAYED_EARLY_GENES	18	18		
DEN_INTERACT_WITH_LCA5	26	24		
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	284	229		
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	170	125		
BENPORATH_ES_1	379	292		
BENPORATH_ES_2	40	21		
BENPORATH_NANOG_TARGETS	988		Rejected!	
BENPORATH_OCT4_TARGETS	290	219		
BENPORATH_SOX2_TARGETS	734		Rejected!	
BENPORATH_NOS_TARGETS	179	135		
BENPORATH_SUZ12_TARGETS	1033	330		
BENPORATH_EED_TARGETS	1058	340		
BENPORATH_ES_WITH_H3K27ME3	1113	328		
BENPORATH_PRC2_TARGETS	649	165		
BENPORATH_MYC_TARGETS_WITH_EBOX	230	186		
BENPORATH_MYC_MAX_TARGETS	775		Rejected!	
BENPORATH_CYCLING_GENES	648		Rejected!	
BENPORATH_PROLIFERATION	147	136		
PETRETTO_CARDIAC_HYPERTROPHY	34	29		
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	202	140		
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	524	466		
STARK_HYPPOCAMPUS_22Q11_DELETION_UP	54	35		
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	22	18		
STARK_BRAIN_22Q11_DELETION	15		Rejected!	
BENPORATH_ES_CORE_NINE	9		Rejected!	
BENPORATH_ES_CORE_NINE_CORRELATED	100	78		
PETRETTO_BLOOD_PRESSURE_UP	12		Rejected!	
PETRETTO_BLOOD_PRESSURE_DN	9		Rejected!	
PETRETTO_HEART_MASS_QTL_CIS_UP	33	26		
PETRETTO_HEART_MASS_QTL_CIS_DN	27	24		
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP	6		Rejected!	
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN	10		Rejected!	
AMIT_EGF_RESPONSE_20_HELA	12		Rejected!	
AMIT_EGF_RESPONSE_40_HELA	42	36		
AMIT_EGF_RESPONSE_60_HELA	47	41		
AMIT_EGF_RESPONSE_120_HELA	68	54		
AMIT_EGF_RESPONSE_240_HELA	59	51		
AMIT_EGF_RESPONSE_480_HELA	164	147		
AMIT_EGF_RESPONSE_20_MCF10A	12		Rejected!	
AMIT_EGF_RESPONSE_40_MCF10A	17	15		
AMIT_EGF_RESPONSE_60_MCF10A	39	34		
AMIT_EGF_RESPONSE_120_MCF10A	41	35		
AMIT_EGF_RESPONSE_240_MCF10A	21	17		
AMIT_EGF_RESPONSE_480_MCF10A	43	31		
AMIT_SERUM_RESPONSE_20_MCF10A	17		Rejected!	
AMIT_SERUM_RESPONSE_40_MCF10A	32	25		
AMIT_SERUM_RESPONSE_60_MCF10A	58	48		
AMIT_SERUM_RESPONSE_120_MCF10A	65	56		
AMIT_SERUM_RESPONSE_240_MCF10A	57	42		
AMIT_SERUM_RESPONSE_480_MCF10A	39	30		
GEORGES_CELL_CYCLE_MIR192_TARGETS	62	58		
GEORGES_TARGETS_OF_MIR192_AND_MIR215	892		Rejected!	
SHEN_SMARCA2_TARGETS_UP	428	400		
SHEN_SMARCA2_TARGETS_DN	320	94		
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	107	76		
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	81	68		
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	27	21		
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	36	21		
JEON_SMAD6_TARGETS_UP	24	19		
JEON_SMAD6_TARGETS_DN	19	17		
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	66	49		
SUNG_METASTASIS_STROMA_UP	110	94		
SUNG_METASTASIS_STROMA_DN	54	43		
SHIN_B_CELL_LYMPHOMA_CLUSTER_1	13		Rejected!	
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	31	25		
SHIN_B_CELL_LYMPHOMA_CLUSTER_3	28	22		
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	18		Rejected!	
SHIN_B_CELL_LYMPHOMA_CLUSTER_6	12		Rejected!	
SHIN_B_CELL_LYMPHOMA_CLUSTER_7	27	23		
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	37	26		
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	19		Rejected!	
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	223	173		
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	105	81		
MORI_PRE_BI_LYMPHOCYTE_UP	81	73		
MORI_PRE_BI_LYMPHOCYTE_DN	78	62		
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	88	82		
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	59	42		
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	77	57		
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	76	68		
MORI_IMMATURE_B_LYMPHOCYTE_UP	50	37		
MORI_IMMATURE_B_LYMPHOCYTE_DN	91	85		
MORI_MATURE_B_LYMPHOCYTE_UP	92	70		
MORI_MATURE_B_LYMPHOCYTE_DN	76	67		
MORI_PLASMA_CELL_UP	53	46		
MORI_PLASMA_CELL_DN	36	24		
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	112	103		
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	17	15		
COLLIS_PRKDC_SUBSTRATES	17	17		
COLLIS_PRKDC_REGULATORS	13		Rejected!	
TOMIDA_LUNG_CANCER_POOR_SURVIVAL	5		Rejected!	
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	56	48		
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	87	36		
KAUFFMANN_DNA_REPAIR_GENES	230	196		
KAUFFMANN_DNA_REPLICATION_GENES	146	125		
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	38	27		
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	13		Rejected!	
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	26		Rejected!	
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	21		Rejected!	
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	38	26		
NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	11		Rejected!	
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	75	47		
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	57	37		
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	132	90		
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	157	99		
NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON	8		Rejected!	
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	158	90		
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	46	33		
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	15		Rejected!	
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	14		Rejected!	
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	22	19		
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	119	72		
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	52	36		
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON	10		Rejected!	
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	133	79		
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	334	218		
NIKOLSKY_BREAST_CANCER_19P13_AMPLICON	5		Rejected!	
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	22		Rejected!	
NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON	7		Rejected!	
NIKOLSKY_BREAST_CANCER_20P13_AMPLICON	8		Rejected!	
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	31	25		
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	149	83		
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	16		Rejected!	
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	17		Rejected!	
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	94	53		
WHITEHURST_PACLITAXEL_SENSITIVITY	38	18		
STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS	11		Rejected!	
TESAR_ALK_TARGETS_HUMAN_ES_4D_DN	6		Rejected!	
TESAR_ALK_TARGETS_HUMAN_ES_5D_UP	5		Rejected!	
TESAR_ALK_TARGETS_HUMAN_ES_5D_DN	7		Rejected!	
JI_METASTASIS_REPRESSED_BY_STK11	26	18		
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	63	54		
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	50	35		
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	75	58		
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	31	22		
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	26	15		
DING_LUNG_CANCER_MUTATED_FREQUENTLY	12		Rejected!	
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	100	97		
ONDER_CDH1_TARGETS_2_UP	257	168		
ONDER_CDH1_TARGETS_2_DN	473	334		
ONDER_CDH1_TARGETS_1_UP	139	100		
ONDER_CDH1_TARGETS_1_DN	170	127		
ONDER_CDH1_TARGETS_3_UP	18		Rejected!	
ONDER_CDH1_TARGETS_3_DN	59	30		
ONDER_CDH1_SIGNALING_VIA_CTNNB1	84	62		
ZEILSTRA_CD44_TARGETS_UP	8		Rejected!	
ZEILSTRA_CD44_TARGETS_DN	9		Rejected!	
CERVERA_SDHB_TARGETS_2	115	61		
ROZANOV_MMP14_TARGETS_SUBSET	33	24		
ROZANOV_MMP14_CORRELATED	11		Rejected!	
ROZANOV_MMP14_TARGETS_UP	267	172		
ROZANOV_MMP14_TARGETS_DN	35	17		
LANDEMAINE_LUNG_METASTASIS	21		Rejected!	
CERVERA_SDHB_TARGETS_1_UP	120	60		
CERVERA_SDHB_TARGETS_1_DN	36	15		
LE_EGR2_TARGETS_DN	105	81		
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	82	56		
BYSTRYKH_SCP2_QTL	6		Rejected!	
KENNY_CTNNB1_TARGETS_UP	50	44		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	21		Rejected!	
NELSON_RESPONSE_TO_ANDROGEN_DN	17		Rejected!	
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	81	67		
BYSTROEM_CORRELATED_WITH_IL5_DN	57	52		
SWEET_KRAS_TARGETS_DN	66	47		
SHEPARD_CRUSH_AND_BURN_MUTANT_UP	205	169		
ROSS_AML_WITH_PML_RARA_FUSION	80	51		
LEI_HOXC8_TARGETS_UP	14		Rejected!	
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	15		Rejected!	
LEE_LIVER_CANCER_CIPROFIBRATE_DN	66	27		
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	161	108		
STANELLE_E2F1_TARGETS	29	20		
CHESLER_BRAIN_D6MIT150_QTL_CIS	6		Rejected!	
SHIPP_DLBCL_CURED_VS_FATAL_DN	44	34		
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	14		Rejected!	
UEDA_CENTRAL_CLOCK	88	75		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3	8		Rejected!	
GOLUB_ALL_VS_AML_UP	24	20		
HOUSTIS_ROS	36	32		
BASSO_B_LYMPHOCYTE_NETWORK	146	125		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	133	115		
SCHUHMACHER_MYC_TARGETS_DN	8		Rejected!	
LEI_HOXC8_TARGETS_DN	17		Rejected!	
CHESLER_BRAIN_QTL_CIS	73	61		
ROSS_AML_WITH_CBFB_MYH11_FUSION	52	37		
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN	10		Rejected!	
FERRANDO_TAL1_NEIGHBORS	20		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	156	120		
LEE_LIVER_CANCER_MYC_TGFA_DN	65	30		
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	25	24		
GOLDRATH_HOMEOSTATIC_PROLIFERATION	147	137		
LAMB_CCND1_TARGETS	20	19		
GNATENKO_PLATELET_SIGNATURE	44	32		
KIM_GERMINAL_CENTER_T_HELPER_UP	64	53		
SHEPARD_BMYB_MORPHOLINO_DN	202	137		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	67	62		
LEE_LIVER_CANCER_ACOX1_DN	65	28		
SMITH_TERT_TARGETS_UP	145	128		
LEE_LIVER_CANCER_MYC_UP	54	45		
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	17	15		
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	68	58		
DER_IFN_ALPHA_RESPONSE_UP	74	64		
KANNAN_TP53_TARGETS_UP	58	46		
WELCH_GATA1_TARGETS	25	15		
FRASOR_RESPONSE_TO_ESTRADIOL_UP	35	18		
LEE_LIVER_CANCER_MYC_TGFA_UP	61	50		
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	42	37		
DORSAM_HOXA9_TARGETS_UP	35	33		
DER_IFN_BETA_RESPONSE_DN	8		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	27	20		
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	58	41		
SHEPARD_BMYB_TARGETS	76	50		
KANNAN_TP53_TARGETS_DN	22	18		
CHANG_POU5F1_TARGETS_UP	15		Rejected!	
CHANG_POU5F1_TARGETS_DN	8		Rejected!	
SANA_TNF_SIGNALING_DN	85	64		
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	396	213		
WILLERT_WNT_SIGNALING	23	19		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1	8		Rejected!	
KENNY_CTNNB1_TARGETS_DN	52	46		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP	10		Rejected!	
CHESLER_BRAIN_QTL_TRANS	6		Rejected!	
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP	12		Rejected!	
BECKER_TAMOXIFEN_RESISTANCE_UP	54	44		
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	191	123		
KIM_GERMINAL_CENTER_T_HELPER_DN	12		Rejected!	
RADAEVA_RESPONSE_TO_IFNA1_UP	47	39		
PEART_HDAC_PROLIFERATION_CLUSTER_UP	53	49		
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	38	24		
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	20	17		
YAGI_AML_RELAPSE_PROGNOSIS	35	29		
SHIPP_DLBCL_CURED_VS_FATAL_UP	39		Rejected!	
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	88	59		
LEE_LIVER_CANCER_ACOX1_UP	65	51		
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN	9		Rejected!	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12		Rejected!	
UEDA_PERIFERAL_CLOCK	169	142		
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	38	30		
CHEN_LUNG_CANCER_SURVIVAL	28	23		
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	62	39		
WIELAND_UP_BY_HBV_INFECTION	103	70		
SHEPARD_BMYB_MORPHOLINO_UP	212	170		
GOLUB_ALL_VS_AML_DN	23	17		
DISTECHE_ESCAPED_FROM_X_INACTIVATION	13		Rejected!	
DER_IFN_BETA_RESPONSE_UP	103	92		
MANALO_HYPOXIA_DN	292	272		
CHESLER_BRAIN_HIGHEST_EXPRESSION	42	31		
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	28	20		
LEE_LIVER_CANCER_MYC_E2F1_DN	64	32		
BYSTROEM_CORRELATED_WITH_IL5_UP	42	30		
CHESLER_BRAIN_D6MIT150_QTL_TRANS	9		Rejected!	
NELSON_RESPONSE_TO_ANDROGEN_UP	83	73		
LIN_APC_TARGETS	71	59		
VANTVEER_BREAST_CANCER_METASTASIS_DN	109	95		
BROCKE_APOPTOSIS_REVERSED_BY_IL6	146	122		
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	61	46		
FRASOR_RESPONSE_TO_ESTRADIOL_DN	78	53		
CHEOK_RESPONSE_TO_HD_MTX_DN	22	18		
TENEDINI_MEGAKARYOCYTE_MARKERS	62	45		
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	307	288		
SMITH_LIVER_CANCER	47	39		
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	62	55		
ROSS_AML_WITH_MLL_FUSIONS	81	57		
GRANDVAUX_IRF3_TARGETS_UP	13		Rejected!	
LEE_LIVER_CANCER_MYC_E2F1_UP	56	48		
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	48	31		
LE_EGR2_TARGETS_UP	111	99		
FERNANDEZ_BOUND_BY_MYC	181	147		
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	153	131		
ROSS_AML_OF_FAB_M7_TYPE	70	45		
MOOTHA_VOXPHOS	87	81		
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	51	42		
DER_IFN_GAMMA_RESPONSE_DN	10		Rejected!	
SANA_RESPONSE_TO_IFNG_UP	76	55		
SANA_TNF_SIGNALING_UP	83	69		
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	48	31		
SCHUHMACHER_MYC_TARGETS_UP	80	75		
SWEET_KRAS_TARGETS_UP	83	66		
CHEOK_RESPONSE_TO_HD_MTX_UP	23	15		
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	20	15		
OKUMURA_INFLAMMATORY_RESPONSE_LPS	182	132		
SMITH_TERT_TARGETS_DN	87	66		
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	45	20		
LEE_LIVER_CANCER_DENA_DN	74	37		
SANA_RESPONSE_TO_IFNG_DN	87	73		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	20		Rejected!	
LEE_LIVER_CANCER_MYC_DN	63	32		
LEE_LIVER_CANCER_CIPROFIBRATE_UP	60	44		
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	20	15		
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	44	40		
LU_IL4_SIGNALING	91	59		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	774		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1	8		Rejected!	
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	24	16		
FERRANDO_LYL1_NEIGHBORS	16		Rejected!	
VANTVEER_BREAST_CANCER_METASTASIS_UP	45	33		
COLLER_MYC_TARGETS_UP	24	22		
MANALO_HYPOXIA_UP	205	165		
REN_BOUND_BY_E2F	62	56		
DORSAM_HOXA9_TARGETS_DN	32	26		
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	553	433		
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	45	42		
GRANDVAUX_IRF3_TARGETS_DN	18		Rejected!	
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE	11		Rejected!	
RADAEVA_RESPONSE_TO_IFNA1_DN	10		Rejected!	
BECKER_TAMOXIFEN_RESISTANCE_DN	54	39		
PEART_HDAC_PROLIFERATION_CLUSTER_DN	71	61		
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	50	38		
SASAKI_ADULT_T_CELL_LEUKEMIA	168	136		
COLLER_MYC_TARGETS_DN	7		Rejected!	
LEE_LIVER_CANCER_E2F1_DN	64	35		
LEE_LIVER_CANCER_DENA_UP	60	50		
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	24	20		
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	41	31		
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	65	57		
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	568		Rejected!	
GOLDRATH_IMMUNE_MEMORY	64	47		
LEE_LIVER_CANCER_E2F1_UP	63	55		
ROSS_AML_WITH_AML1_ETO_FUSION	78	47		
BHATTACHARYA_EMBRYONIC_STEM_CELL	84	65		
OSAWA_TNF_TARGETS	10		Rejected!	
DER_IFN_GAMMA_RESPONSE_UP	71	64		
HASLINGER_B_CLL_WITH_17P13_DELETION	22	19		
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	79	51		
ZHAN_MULTIPLE_MYELOMA_CD1_UP	45	27		
ABBUD_LIF_SIGNALING_1_DN	28	22		
SANSOM_APC_TARGETS_UP	130	116		
NAKAJIMA_EOSINOPHIL	25		Rejected!	
BROWN_MYELOID_CELL_DEVELOPMENT_UP	166	115		
NADLER_OBESITY_UP	60	54		
SANSOM_APC_TARGETS_DN	352	235		
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	74	52		
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	87	65		
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	30	30		
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	82	56		
MA_MYELOID_DIFFERENTIATION_DN	43	29		
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	80	69		
VERNELL_RETINOBLASTOMA_PATHWAY_DN	23	17		
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	18		Rejected!	
CROMER_METASTASIS_UP	72	57		
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	55	42		
GUO_HEX_TARGETS_UP	78	61		
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	24		Rejected!	
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	140	86		
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	48	37		
HEDVAT_ELF4_TARGETS_UP	12		Rejected!	
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	15		Rejected!	
STOSSI_RESPONSE_TO_ESTRADIOL	46	24		
YU_MYC_TARGETS_UP	43	40		
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	76	66		
ABBUD_LIF_SIGNALING_2_UP	12		Rejected!	
PARK_HSC_MARKERS	44	37		
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	89	62		
HOFMANN_CELL_LYMPHOMA_DN	40	25		
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	68	44		
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	485	358		
WANG_TARGETS_OF_MLL_CBP_FUSION_UP	45	36		
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	40	34		
STONER_ESOPHAGEAL_CARCINOGENESIS_DN	6		Rejected!	
HASLINGER_B_CLL_WITH_13Q14_DELETION	24	18		
HOFMANN_CELL_LYMPHOMA_UP	49	37		
GUO_HEX_TARGETS_DN	65	49		
HSIAO_LIVER_SPECIFIC_GENES	250	119		
GILDEA_METASTASIS	29	23		
ZHAN_MULTIPLE_MYELOMA_SPIKED	24		Rejected!	
MUNSHI_MULTIPLE_MYELOMA_DN	10		Rejected!	
ASTIER_INTEGRIN_SIGNALING	57	41		
ZHAN_MULTIPLE_MYELOMA_LB_UP	46	23		
HASLINGER_B_CLL_WITH_11Q23_DELETION	23	16		
LEI_MYB_TARGETS	323	266		
BROWN_MYELOID_CELL_DEVELOPMENT_DN	127	96		
ROETH_TERT_TARGETS_DN	9		Rejected!	
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	85	78		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	164	135		
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	85	65		
HALMOS_CEBPA_TARGETS_DN	45	33		
NADLER_OBESITY_DN	49	41		
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	89	74		
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	31	23		
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	30	25		
GALE_APL_WITH_FLT3_MUTATED_DN	16		Rejected!	
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	94	64		
NADLER_HYPERGLYCEMIA_AT_OBESITY	58	45		
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	28	19		
ZHAN_MULTIPLE_MYELOMA_PR_UP	46	42		
HALMOS_CEBPA_TARGETS_UP	48	34		
YU_MYC_TARGETS_DN	59	40		
NUMATA_CSF3_SIGNALING_VIA_STAT3	21	15		
ZHAN_MULTIPLE_MYELOMA_UP	64	52		
LENAOUR_DENDRITIC_CELL_MATURATION_UP	116	84		
TAVOR_CEBPA_TARGETS_DN	32	17		
LENAOUR_DENDRITIC_CELL_MATURATION_DN	130	94		
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	45	43		
HADDAD_B_LYMPHOCYTE_PROGENITOR	289	178		
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	45	40		
GREENBAUM_E2A_TARGETS_DN	20	18		
NGUYEN_NOTCH1_TARGETS_UP	27	19		
ZHAN_MULTIPLE_MYELOMA_CD2_UP	48	24		
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	23	20		
ABBUD_LIF_SIGNALING_1_UP	43	35		
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	26	21		
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	76	63		
GERY_CEBP_TARGETS	131	99		
VERHAAK_AML_WITH_NPM1_MUTATED_UP	186	100		
KANG_IMMORTALIZED_BY_TERT_UP	88	51		
BASSO_CD40_SIGNALING_DN	71	47		
ZHAN_MULTIPLE_MYELOMA_MF_UP	48	31		
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	162	117		
JAIN_NFKB_SIGNALING	75	70		
ROETH_TERT_TARGETS_UP	14		Rejected!	
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	131	100		
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	183	149		
STAEGE_EWING_FAMILY_TUMOR	32		Rejected!	
GALE_APL_WITH_FLT3_MUTATED_UP	59	50		
AFFAR_YY1_TARGETS_UP	199	116		
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	227	190		
AFFAR_YY1_TARGETS_DN	262	195		
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	49	40		
VERNELL_RETINOBLASTOMA_PATHWAY_UP	70	62		
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	186	130		
KANG_IMMORTALIZED_BY_TERT_DN	101	51		
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	69	59		
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	20	16		
NGUYEN_NOTCH1_TARGETS_DN	83	73		
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	371	186		
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	68	49		
PETROVA_PROX1_TARGETS_DN	56	35		
HOEGERKORP_CD44_TARGETS_DIRECT_DN	14		Rejected!	
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	29	23		
XU_RESPONSE_TO_TRETINOIN_UP	16		Rejected!	
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	20	19		
MENSE_HYPOXIA_UP	97	80		
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	22	16		
ZHAN_V2_LATE_DIFFERENTIATION_GENES	45	39		
DORSEY_GAB2_TARGETS	30	15		
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	64	31		
NAKAJIMA_MAST_CELL	46	29		
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	25	18		
ZHAN_MULTIPLE_MYELOMA_MS_UP	50	31		
MA_MYELOID_DIFFERENTIATION_UP	38	31		
RADMACHER_AML_PROGNOSIS	81	57		
CROMER_METASTASIS_DN	77	68		
NOUZOVA_METHYLATED_IN_APL	66	33		
ZHAN_MULTIPLE_MYELOMA_HP_UP	50	29		
XU_RESPONSE_TO_TRETINOIN_DN	12		Rejected!	
TAVOR_CEBPA_TARGETS_UP	51	36		
YAGI_AML_SURVIVAL	123	93		
XU_CREBBP_TARGETS_UP	22	18		
VERHAAK_AML_WITH_NPM1_MUTATED_DN	250	150		
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	28		Rejected!	
APPEL_IMATINIB_RESPONSE	33	26		
YAGI_AML_FAB_MARKERS	194	138		
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	53	40		
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	175	153		
ABBUD_LIF_SIGNALING_2_DN	6		Rejected!	
XU_CREBBP_TARGETS_DN	41	33		
IGLESIAS_E2F_TARGETS_DN	16		Rejected!	
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP	12		Rejected!	
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	25	18		
IGLESIAS_E2F_TARGETS_UP	145	132		
MUNSHI_MULTIPLE_MYELOMA_UP	77	67		
KAMMINGA_EZH2_TARGETS	41	40		
ZHAN_MULTIPLE_MYELOMA_DN	42	24		
BASSO_CD40_SIGNALING_UP	103	71		
HASLINGER_B_CLL_WITH_6Q21_DELETION	22		Rejected!	
HANSON_HRAS_SIGNALING_VIA_NFKB	23		Rejected!	
FAELT_B_CLL_WITH_VH3_21_DN	49	41		
GREENBAUM_E2A_TARGETS_UP	33	33		
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	14		Rejected!	
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	137	112		
BRUNO_HEMATOPOIESIS	66	51		
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	87	48		
PETROVA_PROX1_TARGETS_UP	25	20		
HOEGERKORP_CD44_TARGETS_DIRECT_UP	26	15		
KUMAR_TARGETS_OF_MLL_AF9_FUSION	401	281		
FAELT_B_CLL_WITH_VH3_21_UP	45	37		
SESTO_RESPONSE_TO_UV_C8	71	64		
KIM_HYPOXIA	17	15		
GENTILE_UV_RESPONSE_CLUSTER_D9	26	24		
LIANG_SILENCED_BY_METHYLATION_2	58	29		
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	443	359		
LY_AGING_PREMATURE_DN	30	26		
MARTINEZ_RESPONSE_TO_TRABECTEDIN	50	45		
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	35	32		
BROWNE_HCMV_INFECTION_20HR_UP	237	180		
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	87	74		
URS_ADIPOCYTE_DIFFERENTIATION_UP	66	45		
LEE_AGING_NEOCORTEX_DN	68	42		
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	99	50		
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	407	375		
TRAYNOR_RETT_SYNDROM_UP	40	20		
MCCLUNG_DELTA_FOSB_TARGETS_8WK	49	34		
BRACHAT_RESPONSE_TO_METHOTREXATE_DN	26	24		
BROWNE_HCMV_INFECTION_16HR_UP	224	174		
MODY_HIPPOCAMPUS_POSTNATAL	56	38		
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS	10		Rejected!	
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	42	25		
BURTON_ADIPOGENESIS_10	31	29		
ABE_VEGFA_TARGETS_2HR	35	23		
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	21		Rejected!	
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	70	54		
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	388	287		
IVANOVA_HEMATOPOIESIS_MATURE_CELL	292	240		
DAZARD_UV_RESPONSE_CLUSTER_G3	14		Rejected!	
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	38	29		
WEBER_METHYLATED_IN_COLON_CANCER	18		Rejected!	
KAAB_FAILED_HEART_ATRIUM_DN	147	138		
SU_PANCREAS	49	22		
RUAN_RESPONSE_TO_TROGLITAZONE_UP	24	19		
WU_HBX_TARGETS_2_DN	16		Rejected!	
ZAMORA_NOS2_TARGETS_UP	56	52		
JIANG_AGING_CEREBRAL_CORTEX_UP	32	26		
WEIGEL_OXIDATIVE_STRESS_RESPONSE	33	29		
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	300	252		
BRACHAT_RESPONSE_TO_CISPLATIN	23	21		
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	515	424		
LU_AGING_BRAIN_DN	153	103		
RUAN_RESPONSE_TO_TNF_UP	12		Rejected!	
WHITESIDE_CISPLATIN_RESISTANCE_UP	11		Rejected!	
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	67	48		
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	60	41		
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	216	132		
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	36	31		
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	38	26		
ZHOU_TNF_SIGNALING_4HR	50	48		
MARCHINI_TRABECTEDIN_RESISTANCE_UP	20		Rejected!	
GENTILE_UV_LOW_DOSE_UP	25	23		
BLALOCK_ALZHEIMERS_DISEASE_DN	1247		Rejected!	
BROWNE_HCMV_INFECTION_16HR_DN	84	56		
WESTON_VEGFA_TARGETS_6HR	50	31		
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	14		Rejected!	
RAMALHO_STEMNESS_DN	74	50		
ONGUSAHA_TP53_TARGETS	39	29		
GENTILE_UV_RESPONSE_CLUSTER_D4	54	51		
RHODES_CANCER_META_SIGNATURE	65	63		
LIAN_LIPA_TARGETS_6M	80	53		
WU_HBX_TARGETS_1_DN	23	19		
HARRIS_HYPOXIA	81	64		
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	39	25		
SU_SALIVARY_GLAND	14		Rejected!	
BROWNE_HCMV_INFECTION_10HR_DN	57	41		
KAYO_CALORIE_RESTRICTION_MUSCLE_DN	87	61		
HENDRICKS_SMARCA4_TARGETS_UP	54	42		
ZHENG_RESPONSE_TO_ARSENITE_DN	12		Rejected!	
MURAKAMI_UV_RESPONSE_6HR_DN	21		Rejected!	
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	42	24		
RAMALHO_STEMNESS_UP	196	191		
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	14		Rejected!	
MCDOWELL_ACUTE_LUNG_INJURY_UP	47	41		
SESTO_RESPONSE_TO_UV_C4	20	19		
WANG_SMARCE1_TARGETS_DN	383	278		
SU_TESTIS	80	45		
TRAYNOR_RETT_SYNDROM_DN	15		Rejected!	
SESTO_RESPONSE_TO_UV_C6	39	37		
MCCLUNG_CREB1_TARGETS_DN	56	38		
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	148	106		
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	16		Rejected!	
SESTO_RESPONSE_TO_UV_C2	54	50		
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	256	173		
HU_GENOTOXIC_DAMAGE_24HR	36	30		
CUI_TCF21_TARGETS_UP	36	22		
HEDENFALK_BREAST_CANCER_BRACX_UP	19	16		
GEISS_RESPONSE_TO_DSRNA_DN	16		Rejected!	
CUI_TCF21_TARGETS_2_DN	850		Rejected!	
VIETOR_IFRD1_TARGETS	24	21		
PAL_PRMT5_TARGETS_UP	203	187		
VARELA_ZMPSTE24_TARGETS_DN	42	27		
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	47	21		
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	15		Rejected!	
HEDENFALK_BREAST_CANCER_BRACX_DN	20	18		
JIANG_AGING_HYPOTHALAMUS_DN	35	27		
CHANG_IMMORTALIZED_BY_HPV31_DN	60	41		
BROWNE_HCMV_INFECTION_24HR_DN	145	105		
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8	10		Rejected!	
CHIBA_RESPONSE_TO_TSA_UP	50	37		
RAMASWAMY_METASTASIS_DN	58	38		
MODY_HIPPOCAMPUS_NEONATAL	32	27		
MCCLUNG_COCAINE_REWARD_5D	75	47		
KAYO_AGING_MUSCLE_UP	242	128		
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	15		Rejected!	
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN	11		Rejected!	
BROWNE_HCMV_INFECTION_14HR_DN	291	203		
DELASERNA_MYOD_TARGETS_DN	57	50		
YAMAZAKI_TCEB3_TARGETS_UP	167	145		
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	50	45		
JIANG_VHL_TARGETS	88	78		
MACLACHLAN_BRCA1_TARGETS_DN	16	15		
LEE_AGING_CEREBELLUM_DN	72	43		
EHRLICH_ICF_SYNDROM_UP	13		Rejected!	
BROWNE_INTERFERON_RESPONSIVE_GENES	67	54		
MCCLUNG_DELTA_FOSB_TARGETS_2WK	49	24		
CUI_TCF21_TARGETS_DN	32	21		
SU_THYMUS	20		Rejected!	
KANG_FLUOROURACIL_RESISTANCE_DN	16		Rejected!	
BROWNE_HCMV_INFECTION_8HR_UP	105	73		
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	71	61		
JI_RESPONSE_TO_FSH_DN	53	49		
WESTON_VEGFA_TARGETS_12HR	27	16		
KRASNOSELSKAYA_ILF3_TARGETS_UP	40	26		
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	28	23		
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	51	42		
BAELDE_DIABETIC_NEPHROPATHY_UP	89	56		
LINDVALL_IMMORTALIZED_BY_TERT_UP	68	55		
WU_HBX_TARGETS_3_UP	18	15		
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	219	166		
MURAKAMI_UV_RESPONSE_6HR_UP	34	28		
BROWNE_HCMV_INFECTION_20HR_DN	101	76		
SIMBULAN_PARP1_TARGETS_UP	31	23		
ULE_SPLICING_VIA_NOVA2	43	27		
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	42	35		
IVANOVA_HEMATOPOIESIS_STEM_CELL	192	129		
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	46	38		
MEDINA_SMARCA4_TARGETS	36	32		
KANG_FLUOROURACIL_RESISTANCE_UP	22	18		
MAHAJAN_RESPONSE_TO_IL1A_DN	70	58		
RUAN_RESPONSE_TO_TNF_DN	79	58		
BLALOCK_ALZHEIMERS_DISEASE_UP	1670		Rejected!	
DELASERNA_MYOD_TARGETS_UP	86	62		
BURTON_ADIPOGENESIS_12	33	30		
LEONARD_HYPOXIA	41	35		
KAYO_AGING_MUSCLE_DN	124	104		
KAAB_FAILED_HEART_ATRIUM_UP	36	21		
INGA_TP53_TARGETS	16		Rejected!	
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	61	44		
DASU_IL6_SIGNALING_SCAR_UP	31	25		
LINDVALL_IMMORTALIZED_BY_TERT_DN	73	58		
DAZARD_RESPONSE_TO_UV_SCC_DN	115	105		
CHIBA_RESPONSE_TO_TSA	45	43		
RODWELL_AGING_KIDNEY_DN	148	98		
YIH_RESPONSE_TO_ARSENITE_C2	14		Rejected!	
KANG_DOXORUBICIN_RESISTANCE_UP	54	52		
BROWNE_HCMV_INFECTION_48HR_DN	483	303		
BROWNE_HCMV_INFECTION_48HR_UP	180	132		
BURTON_ADIPOGENESIS_5	117	109		
WESTON_VEGFA_TARGETS	95	66		
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	102	75		
BROWNE_HCMV_INFECTION_8HR_DN	47	32		
APRELIKOVA_BRCA1_TARGETS	48	44		
VERRECCHIA_RESPONSE_TO_TGFB1_C2	21	19		
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	95	59		
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	33	17		
GENTILE_UV_RESPONSE_CLUSTER_D5	35	29		
BRACHAT_RESPONSE_TO_METHOTREXATE_UP	24	20		
RHODES_UNDIFFERENTIATED_CANCER	69	65		
BROWNE_HCMV_INFECTION_14HR_UP	157	121		
YAMAZAKI_TCEB3_TARGETS_DN	199	164		
LEE_CALORIE_RESTRICTION_MUSCLE_UP	39	29		
MACLACHLAN_BRCA1_TARGETS_UP	21	20		
VERRECCHIA_RESPONSE_TO_TGFB1_C1	19	18		
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	20	16		
LEE_AGING_MUSCLE_DN	41	29		
ZHANG_PROLIFERATING_VS_QUIESCENT	49	45		
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	66	50		
VERRECCHIA_RESPONSE_TO_TGFB1_C5	21	18		
GERHOLD_ADIPOGENESIS_DN	62	58		
LU_AGING_BRAIN_UP	262	209		
BURTON_ADIPOGENESIS_3	102	97		
DAZARD_RESPONSE_TO_UV_NHEK_UP	224	162		
LIAN_LIPA_TARGETS_3M	64	44		
ZHU_CMV_ALL_UP	107	90		
BURTON_ADIPOGENESIS_8	80	69		
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	21	18		
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	16		Rejected!	
BURTON_ADIPOGENESIS_2	71	65		
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	54	50		
XU_GH1_EXOGENOUS_TARGETS_UP	55	18		
ZHU_CMV_8_HR_DN	50	41		
ZHU_CMV_24_HR_DN	84	66		
WU_HBX_TARGETS_3_DN	13		Rejected!	
SU_KIDNEY	15		Rejected!	
GENTILE_UV_RESPONSE_CLUSTER_D2	38	33		
PAL_PRMT5_TARGETS_DN	29	18		
VISALA_AGING_LYMPHOCYTE_DN	19		Rejected!	
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	46	16		
CHEN_ETV5_TARGETS_SERTOLI	25	21		
BROWNE_HCMV_INFECTION_18HR_DN	182	120		
MOREIRA_RESPONSE_TO_TSA_UP	28	23		
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	22	16		
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	98	84		
YIH_RESPONSE_TO_ARSENITE_C4	17		Rejected!	
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	28	21		
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	16		Rejected!	
ZHENG_RESPONSE_TO_ARSENITE_UP	15		Rejected!	
DAZARD_UV_RESPONSE_CLUSTER_G4	20	15		
GENTILE_UV_RESPONSE_CLUSTER_D7	37	33		
EHRLICH_ICF_SYNDROM_DN	17		Rejected!	
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	262	192		
GENTILE_UV_RESPONSE_CLUSTER_D6	35	31		
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	37	32		
BROWNE_HCMV_INFECTION_18HR_UP	173	132		
LEE_AGING_NEOCORTEX_UP	77	66		
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	67	63		
BURTON_ADIPOGENESIS_PEAK_AT_24HR	46	45		
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	30	30		
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	22	20		
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	26	24		
GENTILE_UV_HIGH_DOSE_DN	289	255		
HENDRICKS_SMARCA4_TARGETS_DN	49	31		
HAN_JNK_SINGALING_UP	35	32		
KANG_DOXORUBICIN_RESISTANCE_DN	19	19		
SESTO_RESPONSE_TO_UV_C0	109	100		
MCLACHLAN_DENTAL_CARIES_DN	82	45		
BURTON_ADIPOGENESIS_PEAK_AT_2HR	46	43		
CHEN_PDGF_TARGETS	18	15		
MCCLUNG_CREB1_TARGETS_UP	100	61		
LEE_AGING_CEREBELLUM_UP	82	67		
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	59	51		
TSENG_IRS1_TARGETS_DN	134	96		
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	223	163		
RODWELL_AGING_KIDNEY_UP	500	341		
MCCLUNG_COCAIN_REWARD_4WK	73	50		
ZHOU_TNF_SIGNALING_30MIN	51	49		
WELCSH_BRCA1_TARGETS_UP	201	169		
JACKSON_DNMT1_TARGETS_UP	83	74		
CHANG_IMMORTALIZED_BY_HPV31_UP	72	43		
MODY_HIPPOCAMPUS_PRENATAL	44	41		
BURTON_ADIPOGENESIS_4	45	40		
ZHU_CMV_ALL_DN	119	94		
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	133	119		
GENTILE_UV_HIGH_DOSE_UP	23	15		
SU_LIVER	58	18		
CHIBA_RESPONSE_TO_TSA_DN	21	18		
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	82	30		
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	166	131		
LIANG_SILENCED_BY_METHYLATION_UP	33	19		
SONG_TARGETS_OF_IE86_CMV_PROTEIN	55	48		
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	68	49		
CUI_TCF21_TARGETS_2_UP	433	320		
SESTO_RESPONSE_TO_UV_C1	74	64		
LY_AGING_MIDDLE_UP	14		Rejected!	
WENG_POR_TARGETS_GLOBAL_UP	19	15		
WU_HBX_TARGETS_1_UP	16		Rejected!	
GEISS_RESPONSE_TO_DSRNA_UP	39	29		
ABE_VEGFA_TARGETS	19		Rejected!	
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	36	34		
BURTON_ADIPOGENESIS_1	31	27		
LIANG_SILENCED_BY_METHYLATION_DN	11		Rejected!	
MOREIRA_RESPONSE_TO_TSA_DN	18		Rejected!	
WENG_POR_TARGETS_GLOBAL_DN	25	17		
BURTON_ADIPOGENESIS_7	50	44		
BROWNE_HCMV_INFECTION_10HR_UP	98	66		
LIU_SMARCA4_TARGETS	50	34		
GENTILE_UV_RESPONSE_CLUSTER_D1	17	16		
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	276	231		
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	14		Rejected!	
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	18	15		
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	45	30		
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	26	17		
DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4	11		Rejected!	
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	42	41		
WHITESIDE_CISPLATIN_RESISTANCE_DN	13		Rejected!	
BURTON_ADIPOGENESIS_PEAK_AT_0HR	63	52		
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	49	43		
JACKSON_DNMT1_TARGETS_DN	22	15		
DAZARD_RESPONSE_TO_UV_NHEK_DN	300	271		
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	18		Rejected!	
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	17		Rejected!	
KALMA_E2F1_TARGETS	11		Rejected!	
VERRECCHIA_RESPONSE_TO_TGFB1_C4	11		Rejected!	
ZHU_CMV_24_HR_UP	82	73		
BURTON_ADIPOGENESIS_11	51	47		
BROWNE_HCMV_INFECTION_12HR_UP	113	80		
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	566	393		
RAMASWAMY_METASTASIS_UP	66	57		
DAZARD_RESPONSE_TO_UV_SCC_UP	105	89		
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	94	69		
JIANG_HYPOXIA_NORMAL	200	169		
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	32	21		
ABE_INNER_EAR	44	29		
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	23	19		
TSENG_IRS1_TARGETS_UP	119	87		
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	18	16		
XU_GH1_AUTOCRINE_TARGETS_UP	197	109		
XU_GH1_EXOGENOUS_TARGETS_DN	105	52		
BAELDE_DIABETIC_NEPHROPATHY_DN	436	364		
BROWNE_HCMV_INFECTION_6HR_UP	64	41		
DAZARD_UV_RESPONSE_CLUSTER_G1	62	52		
LY_AGING_OLD_DN	56	52		
WENG_POR_DOSAGE	23	15		
MURAKAMI_UV_RESPONSE_24HR	20		Rejected!	
SEMENZA_HIF1_TARGETS	36	32		
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	52	41		
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	185	128		
VARELA_ZMPSTE24_TARGETS_UP	43	37		
YIH_RESPONSE_TO_ARSENITE_C3	31	24		
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	47	25		
CHENG_RESPONSE_TO_NICKEL_ACETATE	45	39		
TSENG_ADIPOGENIC_POTENTIAL_DN	47	31		
DAZARD_UV_RESPONSE_CLUSTER_G6	145	133		
XU_GH1_AUTOCRINE_TARGETS_DN	131	101		
SESTO_RESPONSE_TO_UV_C7	70	58		
KAAB_FAILED_HEART_VENTRICLE_DN	44	36		
JIANG_HYPOXIA_CANCER	58	47		
ZAMORA_NOS2_TARGETS_DN	81	66		
YIH_RESPONSE_TO_ARSENITE_C1	22	19		
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	160	88		
BURTON_ADIPOGENESIS_PEAK_AT_8HR	38	37		
SIMBULAN_PARP1_TARGETS_DN	17	16		
SAFFORD_T_LYMPHOCYTE_ANERGY	88	62		
WU_HBX_TARGETS_2_UP	23	19		
SESTO_RESPONSE_TO_UV_C5	46	44		
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	17		Rejected!	
LY_AGING_MIDDLE_DN	16	16		
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	25		Rejected!	
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	421	200		
WENG_POR_TARGETS_LIVER_UP	40	33		
HU_GENOTOXIC_DAMAGE_4HR	36	35		
MCDOWELL_ACUTE_LUNG_INJURY_DN	47	34		
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	21	16		
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	47	39		
GENTILE_UV_LOW_DOSE_DN	64	52		
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	19	15		
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	19		Rejected!	
GENTILE_UV_RESPONSE_CLUSTER_D8	37	34		
BROWNE_HCMV_INFECTION_24HR_UP	146	101		
WANG_SMARCE1_TARGETS_UP	292	198		
SESTO_RESPONSE_TO_UV_C3	22	19		
HAN_JNK_SINGALING_DN	39	33		
KRASNOSELSKAYA_ILF3_TARGETS_DN	46	32		
GENTILE_RESPONSE_CLUSTER_D3	53	49		
JI_RESPONSE_TO_FSH_UP	68	55		
LEE_CALORIE_RESTRICTION_MUSCLE_DN	47	42		
ABE_VEGFA_TARGETS_30MIN	29	18		
BROWNE_HCMV_INFECTION_6HR_DN	164	120		
LEE_AGING_MUSCLE_UP	38	26		
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	14		Rejected!	
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN	10		Rejected!	
SASSON_FSH_RESPONSE	8		Rejected!	
CHEN_ETV5_TARGETS_TESTIS	26	15		
ZHU_CMV_8_HR_UP	41	32		
WELCSH_BRCA1_TARGETS_DN	141	130		
DASU_IL6_SIGNALING_SCAR_DN	16		Rejected!	
JIANG_AGING_CEREBRAL_CORTEX_DN	49	38		
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	272	247		
BURTON_ADIPOGENESIS_9	85	70		
URS_ADIPOCYTE_DIFFERENTIATION_DN	31	21		
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN	13		Rejected!	
BROWNE_HCMV_INFECTION_12HR_DN	100	77		
MAHAJAN_RESPONSE_TO_IL1A_UP	77	45		
JIANG_AGING_HYPOTHALAMUS_UP	49	43		
KYNG_RESPONSE_TO_H2O2	66	57		
DAZARD_UV_RESPONSE_CLUSTER_G2	30	22		
VERRECCHIA_RESPONSE_TO_TGFB1_C3	14		Rejected!	
WESTON_VEGFA_TARGETS_3HR	66	48		
TSENG_ADIPOGENIC_POTENTIAL_UP	31	19		
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	31	23		
MCLACHLAN_DENTAL_CARIES_UP	265	167		
GERHOLD_ADIPOGENESIS_UP	48	42		
WENG_POR_TARGETS_LIVER_DN	22	15		
SU_PLACENTA	30		Rejected!	
BURTON_ADIPOGENESIS_6	193	161		
SUZUKI_RESPONSE_TO_TSA	18		Rejected!	
BURTON_ADIPOGENESIS_PEAK_AT_16HR	41	40		
MARCHINI_TRABECTEDIN_RESISTANCE_DN	46	42		
BILD_MYC_ONCOGENIC_SIGNATURE	207	166		
BILD_E2F3_ONCOGENIC_SIGNATURE	245	177		
BILD_HRAS_ONCOGENIC_SIGNATURE	249	183		
BILD_SRC_ONCOGENIC_SIGNATURE	58	49		
BILD_CTNNB1_ONCOGENIC_SIGNATURE	77	66		
DOUGLAS_BMI1_TARGETS_UP	563	422		
DOUGLAS_BMI1_TARGETS_DN	314	258		
KRIGE_AMINO_ACID_DEPRIVATION	29	25		
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	934		Rejected!	
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	940		Rejected!	
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	771		Rejected!	
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	1033		Rejected!	
GHO_ATF5_TARGETS_UP	13		Rejected!	
GHO_ATF5_TARGETS_DN	16	15		
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	92	60		
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	264	225		
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY	15		Rejected!	
LI_CYTIDINE_ANALOG_PATHWAY	17		Rejected!	
KIM_LRRC3B_TARGETS	30	23		
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	77	71		
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	68	59		
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	133	122		
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	20	18		
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	35	28		
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	405	366		
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	379	318		
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP	10		Rejected!	
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN	7		Rejected!	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	534	381		
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	464	195		
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	725		Rejected!	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	307	212		
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	493	400		
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP	10		Rejected!	
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN	10		Rejected!	
SINGH_NFE2L2_TARGETS	14		Rejected!	
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	64	61		
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	49	47		
LOPES_METHYLATED_IN_COLON_CANCER_UP	28		Rejected!	
LOPES_METHYLATED_IN_COLON_CANCER_DN	28	15		
HARRIS_BRAIN_CANCER_PROGENITORS	43	18		
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	21	18		
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	19		Rejected!	
BAFNA_MUC4_TARGETS_UP	5		Rejected!	
HOWLIN_CITED1_TARGETS_1_UP	35	21		
HOWLIN_CITED1_TARGETS_1_DN	37	31		
HOWLIN_CITED1_TARGETS_2_UP	18		Rejected!	
HOWLIN_CITED1_TARGETS_2_DN	17	15		
HILLION_HMGA1_TARGETS	86	64		
HILLION_HMGA1B_TARGETS	85	67		
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	75	65		
LEIN_NEURON_MARKERS	69	25		
LEIN_ASTROCYTE_MARKERS	43	30		
LEIN_OLIGODENDROCYTE_MARKERS	76	50		
LEIN_CHOROID_PLEXUS_MARKERS	105	65		
LEIN_MIDBRAIN_MARKERS	84	40		
LEIN_PONS_MARKERS	93	49		
LEIN_MEDULLA_MARKERS	86	50		
LEIN_CEREBELLUM_MARKERS	86	46		
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	18		Rejected!	
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	37	20		
GAVIN_FOXP3_TARGETS_CLUSTER_T4	96	79		
GAVIN_FOXP3_TARGETS_CLUSTER_T7	100	90		
GAVIN_FOXP3_TARGETS_CLUSTER_P2	80	55		
GAVIN_FOXP3_TARGETS_CLUSTER_P3	164	114		
GAVIN_FOXP3_TARGETS_CLUSTER_P4	101	65		
GAVIN_FOXP3_TARGETS_CLUSTER_P6	91	75		
GAVIN_FOXP3_TARGETS_CLUSTER_P7	92	62		
GAVIN_PDE3B_TARGETS	22	17		
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	19		Rejected!	
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN	5		Rejected!	
ZHENG_BOUND_BY_FOXP3	493	381		
MARSON_BOUND_BY_FOXP3_STIMULATED	997		Rejected!	
MARSON_BOUND_BY_FOXP3_UNSTIMULATED	1205		Rejected!	
MARSON_BOUND_BY_E2F4_UNSTIMULATED	689		Rejected!	
MARSON_FOXP3_TARGETS_STIMULATED_UP	30	15		
MARSON_FOXP3_TARGETS_STIMULATED_DN	11		Rejected!	
MARSON_FOXP3_CORE_DIRECT_TARGETS	19		Rejected!	
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	197	173		
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN	13		Rejected!	
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP	12		Rejected!	
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	39	33		
ZHENG_FOXP3_TARGETS_UP	26	22		
ZHENG_FOXP3_TARGETS_DN	7		Rejected!	
SANSOM_APC_TARGETS	208	171		
SANSOM_APC_MYC_TARGETS	240	220		
SANSOM_APC_TARGETS_REQUIRE_MYC	224	197		
SANSOM_WNT_PATHWAY_REQUIRE_MYC	63	56		
YEGNASUBRAMANIAN_PROSTATE_CANCER	135	73		
RIGGINS_TAMOXIFEN_RESISTANCE_UP	67	44		
RIGGINS_TAMOXIFEN_RESISTANCE_DN	221	175		
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	21		Rejected!	
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	30	25		
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	41	35		
STEIN_ESRRA_TARGETS_UP	385	326		
STEIN_ESRRA_TARGETS_DN	106	91		
WANG_LSD1_TARGETS_UP	24	16		
WANG_LSD1_TARGETS_DN	37	18		
FOSTER_TOLERANT_MACROPHAGE_UP	167	125		
FOSTER_TOLERANT_MACROPHAGE_DN	413	355		
TESAR_ALK_TARGETS_EPISC_3D_UP	7		Rejected!	
TESAR_ALK_TARGETS_EPISC_4D_UP	6		Rejected!	
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP	5		Rejected!	
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN	5		Rejected!	
TESAR_JAK_TARGETS_MOUSE_ES_D3_DN	8		Rejected!	
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	17		Rejected!	
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP	12		Rejected!	
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	25	19		
JEPSEN_SMRT_TARGETS	33	26		
KYNG_DNA_DAMAGE_BY_4NQO	36	25		
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	77	49		
KYNG_DNA_DAMAGE_BY_UV	54	39		
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	15		Rejected!	
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	60	47		
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	77	56		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD	12		Rejected!	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	37	34		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	29	25		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	31	28		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	23	19		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS	12		Rejected!	
KYNG_DNA_DAMAGE_DN	182	150		
KYNG_DNA_DAMAGE_UP	205	139		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	53	48		
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	17	15		
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	97	49		
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	194	38		
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	26	16		
KONDO_COLON_CANCER_HCP_WITH_H3K27ME3	6		Rejected!	
KONDO_EZH2_TARGETS	229	127		
ZHANG_GATA6_TARGETS_UP	16		Rejected!	
ZHANG_GATA6_TARGETS_DN	62	40		
MCGOWAN_RSP6_TARGETS_UP	19		Rejected!	
KANG_CISPLATIN_RESISTANCE_UP	21	16		
KANG_CISPLATIN_RESISTANCE_DN	8		Rejected!	
STEARMAN_TUMOR_FIELD_EFFECT_UP	38	32		
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	128	120		
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	62	51		
HELLER_SILENCED_BY_METHYLATION_UP	283	168		
HELLER_SILENCED_BY_METHYLATION_DN	107	76		
HELLER_HDAC_TARGETS_UP	317	210		
HELLER_HDAC_TARGETS_DN	293	219		
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	462	272		
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	281	209		
CLAUS_PGR_POSITIVE_MENINGIOMA_UP	10		Rejected!	
CLAUS_PGR_POSITIVE_MENINGIOMA_DN	12		Rejected!	
WONG_MITOCHONDRIA_GENE_MODULE	218	201		
WONG_PROTEASOME_GENE_MODULE	50	48		
COATES_MACROPHAGE_M1_VS_M2_UP	86	61		
COATES_MACROPHAGE_M1_VS_M2_DN	85	60		
LEE_METASTASIS_AND_RNA_PROCESSING_UP	16	16		
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	74	47		
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	45	33		
LIN_MELANOMA_COPY_NUMBER_UP	72	56		
LIN_MELANOMA_COPY_NUMBER_DN	41	38		
MARTINEZ_RB1_TARGETS_UP	683		Rejected!	
MARTINEZ_RB1_TARGETS_DN	559	402		
MARTINEZ_TP53_TARGETS_UP	618	480		
MARTINEZ_TP53_TARGETS_DN	604	452		
MARTINEZ_RB1_AND_TP53_TARGETS_UP	617	478		
MARTINEZ_RB1_AND_TP53_TARGETS_DN	600	448		
FINETTI_BREAST_CANCER_KINOME_RED	16	16		
FINETTI_BREAST_CANCER_KINOME_GREEN	16		Rejected!	
FINETTI_BREAST_CANCERS_KINOME_BLUE	21		Rejected!	
FINETTI_BREAST_CANCERS_KINOME_GRAY	15		Rejected!	
MASSARWEH_TAMOXIFEN_RESISTANCE_UP	580	457		
MASSARWEH_TAMOXIFEN_RESISTANCE_DN	256	155		
MASSARWEH_RESPONSE_TO_ESTRADIOL	62	44		
WALLACE_PROSTATE_CANCER_UP	20	19		
WALLACE_PROSTATE_CANCER_DN	6		Rejected!	
WALLACE_PROSTATE_CANCER_RACE_UP	303	165		
WALLACE_PROSTATE_CANCER_RACE_DN	88	60		
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	166	138		
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	145	117		
OUILLETTE_CLL_13Q14_DELETION_UP	75	54		
OUILLETTE_CLL_13Q14_DELETION_DN	56	37		
YOKOE_CANCER_TESTIS_ANTIGENS	35	21		
MARZEC_IL2_SIGNALING_UP	115	86		
MARZEC_IL2_SIGNALING_DN	36	30		
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	192	135		
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	359	240		
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	172	126		
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	122	83		
DER_IFN_ALPHA_RESPONSE_DN	5		Rejected!	
CAMPS_COLON_CANCER_COPY_NUMBER_UP	93	49		
CAMPS_COLON_CANCER_COPY_NUMBER_DN	74	17		
RIZKI_TUMOR_INVASIVENESS_3D_UP	209	141		
RIZKI_TUMOR_INVASIVENESS_3D_DN	262	178		
RIZKI_TUMOR_INVASIVENESS_2D_UP	69	50		
RIZKI_TUMOR_INVASIVENESS_2D_DN	63	52		
FUJII_YBX1_TARGETS_UP	43	28		
FUJII_YBX1_TARGETS_DN	194	174		
OSADA_ASCL1_TARGETS_UP	46	30		
OSADA_ASCL1_TARGETS_DN	24	15		
CHENG_IMPRINTED_BY_ESTRADIOL	110	73		
DE_YY1_TARGETS_UP	20		Rejected!	
DE_YY1_TARGETS_DN	93	84		
MCCABE_BOUND_BY_HOXC6	457	227		
POS_RESPONSE_TO_HISTAMINE_UP	12		Rejected!	
POS_RESPONSE_TO_HISTAMINE_DN	11		Rejected!	
POS_HISTAMINE_RESPONSE_NETWORK	32	24		
DAIRKEE_CANCER_PRONE_RESPONSE_E2	28	17		
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	51	43		
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	118	88		
YAMASHITA_SILENCED_BY_METHYLATION	8		Rejected!	
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	62	34		
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	21	18		
OUYANG_PROSTATE_CANCER_PROGRESSION_DN	21	17		
OUYANG_PROSTATE_CANCER_MARKERS	20	19		
RIGGI_EWING_SARCOMA_PROGENITOR_UP	434	235		
RIGGI_EWING_SARCOMA_PROGENITOR_DN	195	106		
GAUTSCHI_SRC_SIGNALING	8		Rejected!	
VICENT_METASTASIS_UP	14		Rejected!	
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	108	78		
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	36		Rejected!	
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	48	25		
ENGELMANN_CANCER_PROGENITORS_UP	48	40		
ENGELMANN_CANCER_PROGENITORS_DN	69	41		
WORSCHECH_TUMOR_REJECTION_UP	61	29		
WORSCHECH_TUMOR_REJECTION_DN	10		Rejected!	
HUANG_FOXA2_TARGETS_UP	47	31		
HUANG_FOXA2_TARGETS_DN	38	27		
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	20		Rejected!	
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	20		Rejected!	
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	24	18		
MCCABE_HOXC6_TARGETS_UP	10		Rejected!	
MCCABE_HOXC6_TARGETS_DN	21		Rejected!	
TING_SILENCED_BY_DICER	30	16		
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1	12		Rejected!	
MCCABE_HOXC6_TARGETS_CANCER_UP	31	17		
MCCABE_HOXC6_TARGETS_CANCER_DN	20	20		
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	68	32		
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	58	54		
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	173	137		
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	354	290		
ACEVEDO_LIVER_CANCER_UP	972		Rejected!	
ACEVEDO_LIVER_CANCER_DN	540	398		
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	863		Rejected!	
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	274	183		
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	290	126		
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	221	70		
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	139	48		
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	119	50		
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	872	335		
MITSIADES_RESPONSE_TO_APLIDIN_UP	446	339		
MITSIADES_RESPONSE_TO_APLIDIN_DN	250	237		
HOQUE_METHYLATED_IN_CANCER	56	32		
NADELLA_PRKAR1A_TARGETS_UP	9		Rejected!	
NADELLA_PRKAR1A_TARGETS_DN	7		Rejected!	
SAGIV_CD24_TARGETS_UP	22	19		
SAGIV_CD24_TARGETS_DN	45	31		
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	41	24		
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	82	59		
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	99	51		
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	324	176		
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	22		Rejected!	
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	38	16		
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP	6		Rejected!	
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN	10		Rejected!	
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP	6		Rejected!	
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	32		Rejected!	
SMID_BREAST_CANCER_LUMINAL_B_UP	168	91		
SMID_BREAST_CANCER_LUMINAL_B_DN	587	301		
SMID_BREAST_CANCER_LUMINAL_A_UP	85	43		
SMID_BREAST_CANCER_LUMINAL_A_DN	18	17		
SMID_BREAST_CANCER_ERBB2_UP	151	96		
SMID_BREAST_CANCER_ERBB2_DN	5		Rejected!	
SMID_BREAST_CANCER_NORMAL_LIKE_UP	483	224		
SMID_BREAST_CANCER_NORMAL_LIKE_DN	6		Rejected!	
SMID_BREAST_CANCER_BASAL_UP	662	400		
SMID_BREAST_CANCER_BASAL_DN	700	408		
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP	9		Rejected!	
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN	10		Rejected!	
ITO_PTTG1_TARGETS_UP	12		Rejected!	
ITO_PTTG1_TARGETS_DN	9		Rejected!	
LE_SKI_TARGETS_UP	17		Rejected!	
LE_SKI_TARGETS_DN	7		Rejected!	
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	31	20		
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	22	19		
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	237	166		
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	505	372		
GALI_TP53_TARGETS_APOPTOTIC_UP	8		Rejected!	
GALI_TP53_TARGETS_APOPTOTIC_DN	6		Rejected!	
MOSERLE_IFNA_RESPONSE	31	23		
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	42	16		
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	20	18		
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN	5		Rejected!	
WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP	6		Rejected!	
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	43		Rejected!	
WEBER_METHYLATED_HCP_IN_SPERM_DN	29		Rejected!	
WEBER_METHYLATED_HCP_IN_SPERM_UP	20		Rejected!	
BASSO_HAIRY_CELL_LEUKEMIA_UP	79	54		
BASSO_HAIRY_CELL_LEUKEMIA_DN	6		Rejected!	
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	454	373		
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	128	95		
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	107	68		
ZHANG_BREAST_CANCER_PROGENITORS_UP	431	389		
ZHANG_BREAST_CANCER_PROGENITORS_DN	139	121		
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	24	19		
BERNARD_PPAPDC1B_TARGETS_UP	37	34		
BERNARD_PPAPDC1B_TARGETS_DN	58	44		
GAURNIER_PSMD4_TARGETS	73	37		
EHLERS_ANEUPLOIDY_UP	40	31		
EHLERS_ANEUPLOIDY_DN	12		Rejected!	
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	249	192		
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	59	39		
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	21		Rejected!	
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	22	16		
JONES_TCOF1_TARGETS	5		Rejected!	
AUJLA_IL22_AND_IL17A_SIGNALING	11		Rejected!	
ZHENG_IL22_SIGNALING_UP	59	45		
ZHENG_IL22_SIGNALING_DN	41	22		
BOCHKIS_FOXA2_TARGETS	432	325		
HONMA_DOCETAXEL_RESISTANCE	35	34		
WILENSKY_RESPONSE_TO_DARAPLADIB	28	16		
MATZUK_OVULATION	15		Rejected!	
MATZUK_CUMULUS_EXPANSION	9		Rejected!	
MATZUK_FERTILIZATION	8		Rejected!	
MATZUK_MATERNAL_EFFECT	9		Rejected!	
MATZUK_IMPLANTATION_AND_UTERINE	22		Rejected!	
MATZUK_POSTIMPLANTATION_AND_POSTPARTUM	14		Rejected!	
MATZUK_STEROIDOGENESIS	7		Rejected!	
MATZUK_MEIOTIC_AND_DNA_REPAIR	39	22		
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	29		Rejected!	
MATZUK_EMBRYONIC_GERM_CELL	19		Rejected!	
MATZUK_EARLY_ANTRAL_FOLLICLE	13		Rejected!	
MATZUK_LUTEAL_GENES	8		Rejected!	
MATZUK_PREOVULATORY_FOLLICLE	10		Rejected!	
MATZUK_MALE_REPRODUCTION_SERTOLI	28	16		
MATZUK_SPERMATOGONIA	24		Rejected!	
MATZUK_SPERMATOCYTE	72	42		
MATZUK_SPERMATID_DIFFERENTIATION	37	20		
MATZUK_SPERMATOZOA	114	62		
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	92	63		
CHUNG_BLISTER_CYTOTOXICITY_UP	137	104		
CHUNG_BLISTER_CYTOTOXICITY_DN	50	38		
WHITEFORD_PEDIATRIC_CANCER_MARKERS	117	107		
GRADE_COLON_AND_RECTAL_CANCER_UP	290	276		
GRADE_COLON_AND_RECTAL_CANCER_DN	102	59		
GRADE_COLON_VS_RECTAL_CANCER_UP	38	31		
GRADE_COLON_VS_RECTAL_CANCER_DN	56	38		
BOQUEST_STEM_CELL_UP	262	139		
BOQUEST_STEM_CELL_DN	218	146		
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	428	290		
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	31	19		
NAKAMURA_METASTASIS	47	31		
NAKAMURA_METASTASIS_MODEL_UP	45	33		
NAKAMURA_METASTASIS_MODEL_DN	44	29		
GRATIAS_RETINOBLASTOMA_16Q24	18	18		
WEST_ADRENOCORTICAL_TUMOR_UP	298	267		
WEST_ADRENOCORTICAL_TUMOR_DN	543	372		
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	21	15		
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	25		Rejected!	
DONATO_CELL_CYCLE_TRETINOIN	6		Rejected!	
CHO_NR4A1_TARGETS	32	18		
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	121	89		
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	126	83		
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	23	18		
CLIMENT_BREAST_CANCER_COPY_NUMBER_DN	8		Rejected!	
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	27		Rejected!	
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN	7		Rejected!	
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA	10		Rejected!	
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	204	123		
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	265	214		
YAGUE_PRETUMOR_DRUG_RESISTANCE_UP	8		Rejected!	
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN	13		Rejected!	
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	110	86		
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	76	58		
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	149	125		
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	18	17		
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	22		Rejected!	
LU_TUMOR_ENDOTHELIAL_MARKERS_DN	5		Rejected!	
LU_TUMOR_ANGIOGENESIS_UP	25	20		
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	20		Rejected!	
CHEN_HOXA5_TARGETS_6HR_UP	10		Rejected!	
CHEN_HOXA5_TARGETS_6HR_DN	6		Rejected!	
CHEN_HOXA5_TARGETS_9HR_UP	223	179		
CHEN_HOXA5_TARGETS_9HR_DN	42	35		
LIN_NPAS4_TARGETS_UP	171	126		
LIN_NPAS4_TARGETS_DN	71	37		
CADWELL_ATG16L1_TARGETS_UP	104	50		
CADWELL_ATG16L1_TARGETS_DN	65	55		
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	63	48		
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	59	40		
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	52	40		
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	40	33		
CONRAD_STEM_CELL	39	23		
CONRAD_GERMLINE_STEM_CELL	13		Rejected!	
THUM_MIR21_TARGETS_HEART_DISEASE_UP	18		Rejected!	
THUM_MIR21_TARGETS_HEART_DISEASE_DN	9		Rejected!	
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	35	18		
HUANG_DASATINIB_RESISTANCE_UP	80	66		
HUANG_DASATINIB_RESISTANCE_DN	70	60		
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	16		Rejected!	
MATTHEWS_AP1_TARGETS	17	16		
QI_PLASMACYTOMA_UP	253	181		
QI_PLASMACYTOMA_DN	98	84		
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	78	50		
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	54	51		
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	30	28		
HUPER_BREAST_BASAL_VS_LUMINAL_UP	53	32		
HUPER_BREAST_BASAL_VS_LUMINAL_DN	58	42		
MALONEY_RESPONSE_TO_17AAG_UP	40	34		
MALONEY_RESPONSE_TO_17AAG_DN	77	71		
CUI_GLUCOSE_DEPRIVATION	61	47		
BLUM_RESPONSE_TO_SALIRASIB_UP	245	220		
BLUM_RESPONSE_TO_SALIRASIB_DN	341	293		
WINTER_HYPOXIA_METAGENE	243	196		
ALONSO_METASTASIS_EMT_UP	35	29		
ALONSO_METASTASIS_EMT_DN	5		Rejected!	
ALONSO_METASTASIS_NEURAL_UP	18	15		
ALONSO_METASTASIS_UP	194	166		
ALONSO_METASTASIS_DN	26		Rejected!	
CROMER_TUMORIGENESIS_UP	58	37		
CROMER_TUMORIGENESIS_DN	49	33		
KRISHNAN_FURIN_TARGETS_UP	8		Rejected!	
KRISHNAN_FURIN_TARGETS_DN	10		Rejected!	
MUELLER_PLURINET	299	261		
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	146	72		
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	250	76		
FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION	9		Rejected!	
FIRESTEIN_CTNNB1_PATHWAY	32	25		
FIRESTEIN_PROLIFERATION	166	114		
ZHOU_PANCREATIC_EXOCRINE_PROGENITOR	11		Rejected!	
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR	14		Rejected!	
ZHOU_PANCREATIC_BETA_CELL	11		Rejected!	
ISHIKAWA_STING_SIGNALING	9		Rejected!	
WANG_TUMOR_INVASIVENESS_UP	383	351		
WANG_TUMOR_INVASIVENESS_DN	211	194		
JIANG_TIP30_TARGETS_UP	46	41		
JIANG_TIP30_TARGETS_DN	24	20		
GRESHOCK_CANCER_COPY_NUMBER_UP	323	250		
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	22	18		
TSAI_RESPONSE_TO_RADIATION_THERAPY	32	24		
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP	14		Rejected!	
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN	8		Rejected!	
MIKI_COEXPRESSED_WITH_CYP19A1	7		Rejected!	
BEIER_GLIOMA_STEM_CELL_UP	40	22		
BEIER_GLIOMA_STEM_CELL_DN	67	48		
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	163	104		
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	132	68		
MOOTHA_HUMAN_MITODB_6_2002	431	369		
MOOTHA_PGC	421	378		
MOOTHA_TCA	16	15		
LEE_LIVER_CANCER_SURVIVAL_DN	180	161		
LEE_LIVER_CANCER_SURVIVAL_UP	187	90		
MOOTHA_MITOCHONDRIA	450	385		
MOOTHA_ROS	7		Rejected!	
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP	13		Rejected!	
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	26	20		
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	36	31		
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	31	23		
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	27	20		
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	36	27		
BOYLAN_MULTIPLE_MYELOMA_D_UP	90	68		
BOYLAN_MULTIPLE_MYELOMA_D_DN	82	62		
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	141	103		
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	278	176		
BOYLAN_MULTIPLE_MYELOMA_C_UP	49	37		
BOYLAN_MULTIPLE_MYELOMA_C_DN	59	45		
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	52	35		
FERRARI_RESPONSE_TO_FENRETINIDE_UP	22	18		
FERRARI_RESPONSE_TO_FENRETINIDE_DN	5		Rejected!	
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	77	54		
REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS	8		Rejected!	
GU_PDEF_TARGETS_UP	71	59		
GU_PDEF_TARGETS_DN	40	25		
TOOKER_GEMCITABINE_RESISTANCE_UP	80	65		
TOOKER_GEMCITABINE_RESISTANCE_DN	123	114		
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	46	37		
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	38	28		
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	52	45		
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	31	23		
VILIMAS_NOTCH1_TARGETS_UP	51	22		
VILIMAS_NOTCH1_TARGETS_DN	27		Rejected!	
SPIRA_SMOKERS_LUNG_CANCER_UP	39	31		
SPIRA_SMOKERS_LUNG_CANCER_DN	15		Rejected!	
LUDWICZEK_TREATING_IRON_OVERLOAD	7		Rejected!	
JU_AGING_TERC_TARGETS_UP	7		Rejected!	
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS	14		Rejected!	
WAGNER_APO2_SENSITIVITY	26		Rejected!	
PALOMERO_GSI_SENSITIVITY_UP	7		Rejected!	
PALOMERO_GSI_SENSITIVITY_DN	5		Rejected!	
SOUCEK_MYC_TARGETS	12		Rejected!	
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	78	64		
SEKI_INFLAMMATORY_RESPONSE_LPS_DN	22		Rejected!	
RAY_ALZHEIMERS_DISEASE	13		Rejected!	
HUNSBERGER_EXERCISE_REGULATED_GENES	31	16		
PIONTEK_PKD1_TARGETS_UP	38	22		
PIONTEK_PKD1_TARGETS_DN	16		Rejected!	
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	50	43		
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	106	89		
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	23	16		
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	49	47		
GOLDRATH_ANTIGEN_RESPONSE	360	303		
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	117	105		
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	45	27		
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	143	121		
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	54	28		
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	61	41		
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	49	41		
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	63	48		
LINDSTEDT_DENDRITIC_CELL_MATURATION_D	63	49		
MARSHALL_VIRAL_INFECTION_RESPONSE_UP	10		Rejected!	
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	30	22		
MARTINELLI_IMMATURE_NEUTROPHIL_UP	11		Rejected!	
MARTINELLI_IMMATURE_NEUTROPHIL_DN	13		Rejected!	
NICK_RESPONSE_TO_PROC_TREATMENT_DN	27	22		
NUTT_GBM_VS_AO_GLIOMA_UP	46	42		
NUTT_GBM_VS_AO_GLIOMA_DN	46	33		
PARK_APL_PATHOGENESIS_UP	14		Rejected!	
PARK_APL_PATHOGENESIS_DN	48	38		
PARK_TRETINOIN_RESPONSE	12		Rejected!	
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	30	23		
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	23	17		
ZHANG_INTERFERON_RESPONSE	24	20		
WU_ALZHEIMER_DISEASE_UP	14		Rejected!	
WU_ALZHEIMER_DISEASE_DN	19		Rejected!	
MIZUKAMI_HYPOXIA_UP	12		Rejected!	
MIZUKAMI_HYPOXIA_DN	6		Rejected!	
YOSHIMURA_MAPK8_TARGETS_UP	1219		Rejected!	
YOSHIMURA_MAPK8_TARGETS_DN	359	295		
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	66	58		
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	12		Rejected!	
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	16		Rejected!	
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15		Rejected!	
RUIZ_TNC_TARGETS_UP	156	116		
RUIZ_TNC_TARGETS_DN	143	124		
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	341	269		
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	321	231		
RUTELLA_RESPONSE_TO_HGF_UP	422	319		
RUTELLA_RESPONSE_TO_HGF_DN	240	181		
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	412	310		
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	250	190		
SCHRAETS_MLL_TARGETS_UP	33	23		
SCHRAETS_MLL_TARGETS_DN	34	26		
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	14		Rejected!	
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	34	16		
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	80	59		
VANASSE_BCL2_TARGETS_UP	29	20		
VANASSE_BCL2_TARGETS_DN	59	39		
VANTVEER_BREAST_CANCER_ESR1_UP	147	125		
VANTVEER_BREAST_CANCER_ESR1_DN	224	176		
VANTVEER_BREAST_CANCER_BRCA1_UP	34	29		
VANTVEER_BREAST_CANCER_BRCA1_DN	39	30		
WALLACE_JAK2_TARGETS_UP	24	20		
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	301	239		
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	237	202		
SWEET_LUNG_CANCER_KRAS_UP	480	409		
SWEET_LUNG_CANCER_KRAS_DN	422	294		
SWEET_KRAS_ONCOGENIC_SIGNATURE	89	82		
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	84	62		
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	23		Rejected!	
HINATA_NFKB_TARGETS_FIBROBLAST_UP	81	60		
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	29	23		
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	76	59		
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	152	143		
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	65	44		
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	66	47		
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	38	27		
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	41	28		
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	48	34		
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	21		Rejected!	
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	29	23		
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP	10		Rejected!	
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	20		Rejected!	
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	23	19		
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	23		Rejected!	
LEE_EARLY_T_LYMPHOCYTE_UP	109	87		
LEE_EARLY_T_LYMPHOCYTE_DN	58	35		
LEE_INTRATHYMIC_T_PROGENITOR	20		Rejected!	
LEE_DOUBLE_POLAR_THYMOCYTE	28		Rejected!	
LEE_SP4_THYMOCYTE	15		Rejected!	
LEE_RECENT_THYMIC_EMIGRANT	234	178		
LEE_NAIVE_T_LYMPHOCYTE	20		Rejected!	
LEE_DIFFERENTIATING_T_LYMPHOCYTE	200	130		
LI_WILMS_TUMOR	27		Rejected!	
FINAK_BREAST_CANCER_SDPP_SIGNATURE	26		Rejected!	
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	460	390		
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	197	127		
BRUNEAU_SEPTATION_ATRIAL	5		Rejected!	
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	69	47		
BRUNEAU_SEPTATION_VENTRICULAR	10		Rejected!	
BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS	8		Rejected!	
MELLMAN_TUT1_TARGETS_UP	20	19		
MELLMAN_TUT1_TARGETS_DN	47	36		
HAN_SATB1_TARGETS_UP	425	311		
HAN_SATB1_TARGETS_DN	388	281		
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	320	151		
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	359	289		
CHEN_METABOLIC_SYNDROM_NETWORK	1242		Rejected!	
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	27	19		
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	67	38		
MIKKELSEN_PLURIPOTENT_STATE_UP	11		Rejected!	
MIKKELSEN_PLURIPOTENT_STATE_DN	8		Rejected!	
MIKKELSEN_DEDIFFERENTIATED_STATE_UP	8		Rejected!	
MIKKELSEN_DEDIFFERENTIATED_STATE_DN	7		Rejected!	
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY	10		Rejected!	
ELLWOOD_MYC_TARGETS_UP	14		Rejected!	
ELLWOOD_MYC_TARGETS_DN	42	38		
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	36	29		
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	101	90		
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	67	55		
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	81	72		
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	65	55		
HSIAO_HOUSEKEEPING_GENES	398	368		
MEISSNER_ES_ICP_WITH_H3K4ME3	32	19		
MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	14		Rejected!	
MEISSNER_NPC_HCP_WITH_H3K27ME3	79	21		
MEISSNER_NPC_ICP_WITH_H3K4ME3	19	15		
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	143	48		
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	542	222		
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	21		Rejected!	
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	271	75		
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	31	19		
MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	1071		Rejected!	
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	40		Rejected!	
TAVAZOIE_METASTASIS	108	51		
WENDT_COHESIN_TARGETS_UP	32	30		
FERRANDO_HOX11_NEIGHBORS	23	16		
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP	5		Rejected!	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	25	20		
ZHAN_EARLY_DIFFERENTIATION_GENES_UP	7		Rejected!	
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	42	33		
MILI_PSEUDOPODIA	50	46		
MILI_PSEUDOPODIA_CHEMOTAXIS_UP	86	77		
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	435	394		
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	522	492		
MILI_PSEUDOPODIA_HAPTOTAXIS_DN	675		Rejected!	
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	89	65		
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	17		Rejected!	
CROONQUIST_IL6_DEPRIVATION_UP	17		Rejected!	
CROONQUIST_IL6_DEPRIVATION_DN	95	85		
CROONQUIST_STROMAL_STIMULATION_UP	56	43		
CROONQUIST_STROMAL_STIMULATION_DN	13		Rejected!	
CROONQUIST_NRAS_SIGNALING_UP	40	24		
CROONQUIST_NRAS_SIGNALING_DN	70	64		
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	41	30		
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	97	80		
IRITANI_MAD1_TARGETS_UP	13		Rejected!	
IRITANI_MAD1_TARGETS_DN	46	43		
ZHAN_LATE_DIFFERENTIATION_GENES_UP	33	26		
ZHAN_LATE_DIFFERENTIATION_GENES_DN	17		Rejected!	
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	17		Rejected!	
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	31	29		
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	33	32		
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	16		Rejected!	
ISHIDA_E2F_TARGETS	52	51		
VALK_AML_CLUSTER_1	29	17		
VALK_AML_CLUSTER_2	29	16		
VALK_AML_CLUSTER_3	34	20		
VALK_AML_CLUSTER_4	30	20		
VALK_AML_CLUSTER_5	32	16		
VALK_AML_CLUSTER_6	34	23		
VALK_AML_CLUSTER_7	27		Rejected!	
VALK_AML_CLUSTER_8	26	16		
VALK_AML_CLUSTER_9	35	21		
VALK_AML_CLUSTER_10	33	21		
VALK_AML_CLUSTER_11	38	33		
VALK_AML_CLUSTER_12	30	15		
VALK_AML_CLUSTER_13	31	16		
VALK_AML_CLUSTER_15	31	26		
VALK_AML_CLUSTER_16	29	16		
VALK_AML_WITH_T_8_21_TRANSLOCATION	5		Rejected!	
VALK_AML_WITH_11Q23_REARRANGED	24		Rejected!	
VALK_AML_WITH_EVI1	25	16		
VALK_AML_WITH_CEBPA	37	27		
VALK_AML_WITH_FLT3_ITD	41	21		
JISON_SICKLE_CELL_DISEASE_UP	182	137		
JISON_SICKLE_CELL_DISEASE_DN	186	148		
POOLA_INVASIVE_BREAST_CANCER_UP	292	165		
POOLA_INVASIVE_BREAST_CANCER_DN	132	79		
DING_LUNG_CANCER_MUTATED_RECURRENTLY	6		Rejected!	
DING_LUNG_CANCER_BY_MUTATION_RATE	20		Rejected!	
TCGA_GLIOBLASTOMA_MUTATED	8		Rejected!	
CHEN_LIVER_METABOLISM_QTL_CIS	95	64		
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	116	95		
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	40	32		
BOYAULT_LIVER_CANCER_SUBCLASS_G2	28	19		
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	190	182		
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	53	28		
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	28	20		
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	66	41		
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	19	17		
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	40	35		
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	15		Rejected!	
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	53	47		
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN	10		Rejected!	
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	11		Rejected!	
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17	16		
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	47	40		
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	51	30		
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	175	93		
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	170	115		
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	178	155		
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	179	80		
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	26		Rejected!	
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	52	29		
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	79	42		
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	25	19		
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	86	57		
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	194	177		
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	109	97		
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	138	116		
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	62	42		
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	70	42		
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	73	57		
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	113	84		
KAPOSI_LIVER_CANCER_MET_UP	18	18		
KAPOSI_LIVER_CANCER_MET_DN	6		Rejected!	
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	53	43		
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	17		Rejected!	
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	47	38		
YAMASHITA_LIVER_CANCER_STEM_CELL_DN	76	37		
LEE_LIVER_CANCER_HEPATOBLAST	16		Rejected!	
WANG_RECURRENT_LIVER_CANCER_UP	20	20		
WANG_RECURRENT_LIVER_CANCER_DN	16		Rejected!	
WOO_LIVER_CANCER_RECURRENCE_UP	105	80		
WOO_LIVER_CANCER_RECURRENCE_DN	78	49		
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP	11		Rejected!	
YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN	8		Rejected!	
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP	12		Rejected!	
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN	11		Rejected!	
YAGI_AML_WITH_T_8_21_TRANSLOCATION	371	265		
YAGI_AML_WITH_INV_16_TRANSLOCATION	411	281		
YAGI_AML_WITH_T_9_11_TRANSLOCATION	132	88		
YAGI_AML_WITH_11Q23_REARRANGED	345	246		
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	350	94		
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	60	25		
MEISSNER_NPC_HCP_WITH_H3K4ME2	491	228		
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	18		Rejected!	
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	436	79		
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	34		Rejected!	
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	76		Rejected!	
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	26		Rejected!	
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	163	111		
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	39		Rejected!	
MIKKELSEN_MEF_ICP_WITH_H3K27ME3	206	42		
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	71	15		
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	130	86		
MIKKELSEN_IPS_WITH_HCP_H3K27ME3	102	18		
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	84		Rejected!	
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	123	35		
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	55		Rejected!	
MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3	5		Rejected!	
MIKKELSEN_IPS_LCP_WITH_H3K27ME3	10		Rejected!	
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	175	84		
GLINSKY_CANCER_DEATH_UP	7		Rejected!	
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	12		Rejected!	
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	6		Rejected!	
MARSON_FOXP3_TARGETS_UP	67	59		
MARSON_FOXP3_TARGETS_DN	54	41		
ONO_AML1_TARGETS_UP	24		Rejected!	
ONO_AML1_TARGETS_DN	41	20		
ONO_FOXP3_TARGETS_UP	23		Rejected!	
ONO_FOXP3_TARGETS_DN	42	22		
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	67	51		
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	20		Rejected!	
SCHOEN_NFKB_SIGNALING	34	28		
NGO_MALIGNANT_GLIOMA_1P_LOH	15	15		
YANAGISAWA_LUNG_CANCER_RECURRENCE	9		Rejected!	
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	82	64		
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	45	22		
TSAI_DNAJB4_TARGETS_UP	13		Rejected!	
TSAI_DNAJB4_TARGETS_DN	6		Rejected!	
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	43	23		
LI_PROSTATE_CANCER_EPIGENETIC	32	22		
UROSEVIC_RESPONSE_TO_IMIQUIMOD	19	15		
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	45	21		
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	20		Rejected!	
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	78	56		
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	70	47		
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	38	25		
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	26	16		
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	66	47		
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	80	39		
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	16		Rejected!	
WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP	13		Rejected!	
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN	10		Rejected!	
WEBER_METHYLATED_ICP_IN_FIBROBLAST	21		Rejected!	
WEBER_METHYLATED_ICP_IN_SPERM_UP	8		Rejected!	
WEBER_METHYLATED_ICP_IN_SPERM_DN	13		Rejected!	
WEBER_METHYLATED_LCP_IN_SPERM_UP	15		Rejected!	
WEBER_METHYLATED_LCP_IN_SPERM_DN	8		Rejected!	
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	55	53		
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN	9		Rejected!	
GYORFFY_DOXORUBICIN_RESISTANCE	39	22		
GYORFFY_MITOXANTRONE_RESISTANCE	35	17		
SYED_ESTRADIOL_RESPONSE	18	16		
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	32	17		
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN	14		Rejected!	
STEIN_ESR1_TARGETS	83	68		
STEIN_ESRRA_TARGETS	530	448		
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18		Rejected!	
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	82	74		
LOPEZ_EPITHELIOID_MESOTHELIOMA	17		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP	8		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	15		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_UP	12		Rejected!	
LOPEZ_MESOTHELIOMA_SURVIVAL_DN	12		Rejected!	
KORKOLA_CORRELATED_WITH_POU5F1	32	16		
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	24		Rejected!	
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	25		Rejected!	
KOBAYASHI_EGFR_SIGNALING_24HR_UP	102	76		
KOBAYASHI_EGFR_SIGNALING_24HR_DN	252	229		
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	281	265		
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	123	71		
BOYLAN_MULTIPLE_MYELOMA_PCA1_DN	9		Rejected!	
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	83	53		
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	70	50		
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	235	204		
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	115	101		
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	266	176		
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	190	156		
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	29		Rejected!	
CAIRO_HEPATOBLASTOMA_UP	213	179		
CAIRO_HEPATOBLASTOMA_DN	267	154		
CAIRO_HEPATOBLASTOMA_CLASSES_UP	612		Rejected!	
CAIRO_HEPATOBLASTOMA_CLASSES_DN	215	129		
CAIRO_LIVER_DEVELOPMENT_UP	166	111		
CAIRO_LIVER_DEVELOPMENT_DN	223	134		
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	16		Rejected!	
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	12		Rejected!	
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	56	34		
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP	10		Rejected!	
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN	9		Rejected!	
GUTIERREZ_MULTIPLE_MYELOMA_UP	36	32		
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2	13		Rejected!	
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	162	152		
HAHTOLA_CTCL_CUTANEOUS	26	16		
HAHTOLA_CTCL_PATHOGENESIS	15		Rejected!	
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	36	27		
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	49	35		
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	77	60		
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	186	140		
KYNG_NORMAL_AGING_UP	15		Rejected!	
KYNG_NORMAL_AGING_DN	18	15		
KYNG_WERNER_SYNDROM_UP	14		Rejected!	
KYNG_WERNER_SYNDROM_DN	19	15		
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	30	20		
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	19	16		
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA	9		Rejected!	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	26		Rejected!	
ZHAN_MULTIPLE_MYELOMA_CD1_DN	47	35		
ZHAN_MULTIPLE_MYELOMA_CD2_DN	47	37		
ZHAN_MULTIPLE_MYELOMA_LB_DN	39	27		
ZHAN_MULTIPLE_MYELOMA_HP_DN	46	39		
ZHAN_MULTIPLE_MYELOMA_MF_DN	42	29		
ZHAN_MULTIPLE_MYELOMA_MS_DN	45	33		
ZHAN_MULTIPLE_MYELOMA_PR_DN	49	34		
DANG_REGULATED_BY_MYC_UP	68	62		
DANG_REGULATED_BY_MYC_DN	251	214		
DANG_MYC_TARGETS_UP	130	118		
DANG_MYC_TARGETS_DN	31	27		
DANG_BOUND_BY_MYC	1061		Rejected!	
DORN_ADENOVIRUS_INFECTION_12HR_UP	28	19		
DORN_ADENOVIRUS_INFECTION_12HR_DN	33	27		
DORN_ADENOVIRUS_INFECTION_24HR_UP	12		Rejected!	
DORN_ADENOVIRUS_INFECTION_24HR_DN	42	33		
DORN_ADENOVIRUS_INFECTION_32HR_UP	11		Rejected!	
DORN_ADENOVIRUS_INFECTION_32HR_DN	38	32		
DORN_ADENOVIRUS_INFECTION_48HR_UP	14		Rejected!	
DORN_ADENOVIRUS_INFECTION_48HR_DN	39	31		
TIAN_TNF_SIGNALING_VIA_NFKB	26	19		
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	22	18		
WONG_EMBRYONIC_STEM_CELL_CORE	335	315		
WONG_ADULT_TISSUE_STEM_MODULE	719		Rejected!	
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	83	46		
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	77	36		
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	89	60		
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	85	41		
CHANDRAN_METASTASIS_UP	207	148		
CHANDRAN_METASTASIS_DN	313	205		
MIKKELSEN_ES_HCP_WITH_H3K27ME3	41		Rejected!	
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	66		Rejected!	
MIKKELSEN_ES_ICP_WITH_H3K27ME3	43		Rejected!	
MIKKELSEN_ES_ICP_WITH_H3K4ME3	732	425		
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	135	37		
MIKKELSEN_ES_LCP_WITH_H3K27ME3	14		Rejected!	
MIKKELSEN_ES_LCP_WITH_H3K4ME3	145	59		
MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3	7		Rejected!	
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	345	97		
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	210	69		
MIKKELSEN_NPC_ICP_WITH_H3K27ME3	12		Rejected!	
MIKKELSEN_NPC_ICP_WITH_H3K4ME3	451	292		
MIKKELSEN_NPC_WITH_LCP_H3K27ME3	9		Rejected!	
MIKKELSEN_NPC_LCP_WITH_H3K4ME3	59	28		
MIKKELSEN_MEF_HCP_WITH_H3K27ME3	590	107		
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	237	41		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	71	59		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	70	56		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	56	34		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	17		Rejected!	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	15		Rejected!	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	30	23		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	76	61		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	73	67		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	50	43		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	78	69		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	70	67		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	100	93		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	79	69		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	179	164		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	144	136		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	35	27		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	78	59		
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	184	179		
SENGUPTA_EBNA1_ANTICORRELATED	160	86		
YIH_RESPONSE_TO_ARSENITE_C5	11		Rejected!	
MOOTHA_PYR	8		Rejected!	
MOOTHA_FFA_OXYDATION	23	22		
MOOTHA_GLUCONEOGENESIS	31	21		
MOOTHA_GLYCOGEN_METABOLISM	21		Rejected!	
MOOTHA_GLYCOLYSIS	21		Rejected!	
LY_AGING_OLD_UP	7		Rejected!	
NAKAMURA_ADIPOGENESIS_EARLY_UP	62	39		
NAKAMURA_ADIPOGENESIS_EARLY_DN	35	24		
NAKAMURA_ADIPOGENESIS_LATE_UP	97	81		
NAKAMURA_ADIPOGENESIS_LATE_DN	35	26		
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN	10		Rejected!	
VERRECCHIA_RESPONSE_TO_TGFB1_C6	5		Rejected!	
BAUS_TFF2_TARGETS_UP	32	26		
BAUS_TFF2_TARGETS_DN	12		Rejected!	
KAMMINGA_SENESCENCE	40	27		
HO_LIVER_CANCER_VASCULAR_INVASION	13		Rejected!	
GERHOLD_RESPONSE_TO_TZD_UP	6		Rejected!	
GERHOLD_RESPONSE_TO_TZD_DN	13		Rejected!	
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1	8		Rejected!	
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2	8		Rejected!	
MURAKAMI_UV_RESPONSE_1HR_UP	15		Rejected!	
MURAKAMI_UV_RESPONSE_1HR_DN	10		Rejected!	
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	36	33		
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	45	37		
VISALA_AGING_LYMPHOCYTE_UP	7		Rejected!	
DAZARD_UV_RESPONSE_CLUSTER_G5	12		Rejected!	
DAZARD_UV_RESPONSE_CLUSTER_G24	24	15		
DAZARD_UV_RESPONSE_CLUSTER_G28	20	15		
RUAN_RESPONSE_TO_TROGLITAZONE_DN	16		Rejected!	
DASU_IL6_SIGNALING_UP	61	45		
DASU_IL6_SIGNALING_DN	7		Rejected!	
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN	9		Rejected!	
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP	9		Rejected!	
HOFFMAN_CLOCK_TARGETS_UP	10		Rejected!	
HOFFMAN_CLOCK_TARGETS_DN	10		Rejected!	
WHITFIELD_CELL_CYCLE_LITERATURE	44	41		
JIANG_HYPOXIA_VIA_VHL	19	17		
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	53	47		
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	11		Rejected!	
ONGUSAHA_BRCA1_TARGETS_UP	13		Rejected!	
ONGUSAHA_BRCA1_TARGETS_DN	11		Rejected!	
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	86	72		
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	86	74		
SASSON_RESPONSE_TO_FORSKOLIN_UP	88	73		
SASSON_RESPONSE_TO_FORSKOLIN_DN	85	74		
BAE_BRCA1_TARGETS_UP	71	61		
BAE_BRCA1_TARGETS_DN	30	25		
BROWNE_HCMV_INFECTION_30MIN_UP	54	28		
BROWNE_HCMV_INFECTION_30MIN_DN	144	85		
BROWNE_HCMV_INFECTION_1HR_UP	52	27		
BROWNE_HCMV_INFECTION_1HR_DN	218	141		
BROWNE_HCMV_INFECTION_2HR_UP	40	24		
BROWNE_HCMV_INFECTION_2HR_DN	48	40		
BROWNE_HCMV_INFECTION_4HR_UP	50	34		
BROWNE_HCMV_INFECTION_4HR_DN	253	172		
WHITFIELD_CELL_CYCLE_G1_S	133	108		
WHITFIELD_CELL_CYCLE_S	149	102		
WHITFIELD_CELL_CYCLE_G2	168	142		
WHITFIELD_CELL_CYCLE_G2_M	198	167		
WHITFIELD_CELL_CYCLE_M_G1	126	106		
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	71	54		
KARLSSON_TGFB1_TARGETS_UP	123	114		
KARLSSON_TGFB1_TARGETS_DN	195	176		
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	22	18		
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	32	24		
WANG_METASTASIS_OF_BREAST_CANCER	16		Rejected!	
LI_INDUCED_T_TO_NATURAL_KILLER_UP	314	226		
LI_INDUCED_T_TO_NATURAL_KILLER_DN	136	99		
NOUSHMEHR_GBM_SOMATIC_MUTATED	9		Rejected!	
NOUSHMEHR_GBM_GERMLINE_MUTATED	8		Rejected!	
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	50	25		
KAMIKUBO_MYELOID_CEBPA_NETWORK	30	26		
KAMIKUBO_MYELOID_MN1_NETWORK	19	18		
MARTENS_BOUND_BY_PML_RARA_FUSION	455	334		
MARTENS_TRETINOIN_RESPONSE_UP	856	258		
MARTENS_TRETINOIN_RESPONSE_DN	839		Rejected!	
STAMBOLSKY_BOUND_BY_MUTATED_TP53	18		Rejected!	
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	49	31		
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	51	37		
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	84	52		
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	25		Rejected!	
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	755		Rejected!	
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	33	16		
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP	680		Rejected!	
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	87	33		
KIM_ALL_DISORDERS_CALB1_CORR_UP	546	421		
KIM_ALL_DISORDERS_CALB1_CORR_DN	36	17		
KIM_ALL_DISORDERS_DURATION_CORR_UP	9		Rejected!	
KIM_ALL_DISORDERS_DURATION_CORR_DN	145	121		
VERHAAK_GLIOBLASTOMA_PRONEURAL	177	75		
VERHAAK_GLIOBLASTOMA_NEURAL	128	72		
VERHAAK_GLIOBLASTOMA_CLASSICAL	161	110		
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	216	172		
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	242	204		
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	102	89		
CHICAS_RB1_TARGETS_SENESCENT	563	422		
CHICAS_RB1_TARGETS_LOW_SERUM	102	71		
CHICAS_RB1_TARGETS_GROWING	243	183		
CHICAS_RB1_TARGETS_CONFLUENT	566	386		
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	392	232		
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	371	312		
QI_HYPOXIA	132	110		
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	35	30		
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	145	104		
LU_EZH2_TARGETS_UP	288	198		
LU_EZH2_TARGETS_DN	400	290		
HOELZEL_NF1_TARGETS_UP	140	79		
HOELZEL_NF1_TARGETS_DN	118	51		
DEMAGALHAES_AGING_UP	54	44		
DEMAGALHAES_AGING_DN	16		Rejected!	
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	228	191		
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	91	63		
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	323	281		
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	504	407		
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	122	61		
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	45	29		
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	54	27		
FIGUEROA_AML_METHYLATION_CLUSTER_2_DN	9		Rejected!	
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	170	94		
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	40	23		
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	112	64		
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN	15		Rejected!	
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP	12		Rejected!	
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	47	25		
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	140	86		
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	37	16		
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	118	75		
FIGUEROA_AML_METHYLATION_CLUSTER_7_DN	5		Rejected!	
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	27	18		
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	27	20		
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	134	94		
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	145	109		
TSUTSUMI_FBXW8_TARGETS	9		Rejected!	
LI_DCP2_BOUND_MRNA	89	80		
WAGSCHAL_EHMT2_TARGETS_UP	19		Rejected!	
SUBTIL_PROGESTIN_TARGETS	36	30		
OHGUCHI_LIVER_HNF4A_TARGETS_UP	50	27		
OHGUCHI_LIVER_HNF4A_TARGETS_DN	168	58		
GABRIELY_MIR21_TARGETS	289	243		
THILLAINADESAN_ZNF217_TARGETS_UP	41	37		
THILLAINADESAN_ZNF217_TARGETS_DN	9		Rejected!	
PHESSE_TARGETS_OF_APC_AND_MBD2_UP	18		Rejected!	
PHESSE_TARGETS_OF_APC_AND_MBD2_DN	11		Rejected!	
CHYLA_CBFA2T3_TARGETS_UP	386	229		
CHYLA_CBFA2T3_TARGETS_DN	240	149		
FUKUSHIMA_TNFSF11_TARGETS	16		Rejected!	
CARD_MIR302A_TARGETS	77	57		
WIERENGA_STAT5A_TARGETS_UP	202	121		
WIERENGA_STAT5A_TARGETS_DN	193	113		
WIERENGA_STAT5A_TARGETS_GROUP1	127	75		
WIERENGA_STAT5A_TARGETS_GROUP2	54	32		
WIERENGA_PML_INTERACTOME	42	36		
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	84	73		
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	116	83		
KANG_AR_TARGETS_UP	17		Rejected!	
KANG_AR_TARGETS_DN	18		Rejected!	
PILON_KLF1_TARGETS_UP	501	378		
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	211	148		
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	88	70		
BHAT_ESR1_TARGETS_VIA_AKT1_UP	281	213		
BHAT_ESR1_TARGETS_VIA_AKT1_DN	82	62		
JOHNSTONE_PARVB_TARGETS_1_UP	7		Rejected!	
JOHNSTONE_PARVB_TARGETS_1_DN	62	46		
JOHNSTONE_PARVB_TARGETS_2_UP	144	124		
JOHNSTONE_PARVB_TARGETS_2_DN	341	295		
JOHNSTONE_PARVB_TARGETS_3_UP	433	365		
JOHNSTONE_PARVB_TARGETS_3_DN	870		Rejected!	
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	878	485		
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	549	385		
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	89	55		
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	275	167		
BRUINS_UVC_RESPONSE_LATE	1123		Rejected!	
BRUINS_UVC_RESPONSE_EARLY_LATE	309	251		
BRUINS_UVC_RESPONSE_MIDDLE	99	80		
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	40		Rejected!	
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	41		Rejected!	
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	264	175		
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	235	144		
IVANOVSKA_MIR106B_TARGETS	88	74		
KIM_GLIS2_TARGETS_UP	86	74		
KIM_GLIS2_TARGETS_DN	6		Rejected!	
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP	7		Rejected!	
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN	6		Rejected!	
STEGER_ADIPOGENESIS_UP	21		Rejected!	
STEGER_ADIPOGENESIS_DN	25	22		
ZHU_SKIL_TARGETS_UP	20	16		
ZHU_SKIL_TARGETS_DN	9		Rejected!	
KIM_PTEN_TARGETS_UP	18		Rejected!	
KIM_PTEN_TARGETS_DN	5		Rejected!	
ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS	6		Rejected!	
MAEKAWA_ATF2_TARGETS	23		Rejected!	
ISSAEVA_MLL2_TARGETS	61	41		
LINSLEY_MIR16_TARGETS	206	190		
CHENG_TAF7L_TARGETS	6		Rejected!	
CHANGOLKAR_H2AFY_TARGETS_UP	49	41		
CHANGOLKAR_H2AFY_TARGETS_DN	42	30		
PASINI_SUZ12_TARGETS_UP	112	68		
PASINI_SUZ12_TARGETS_DN	316	271		
BAKKER_FOXO3_TARGETS_UP	54	49		
BAKKER_FOXO3_TARGETS_DN	175	131		
BERGER_MBD2_TARGETS	7		Rejected!	
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP	15		Rejected!	
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	82	56		
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	37		Rejected!	
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	17		Rejected!	
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	17		Rejected!	
VANDESLUIS_NORMAL_EMBRYOS_UP	5		Rejected!	
VANDESLUIS_NORMAL_EMBRYOS_DN	21		Rejected!	
SUMI_HNF4A_TARGETS	30		Rejected!	
WANG_NFKB_TARGETS	24		Rejected!	
WANG_TNF_TARGETS	24		Rejected!	
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	126	87		
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	18		Rejected!	
AZARE_STAT3_TARGETS	24	22		
DELPUECH_FOXO3_TARGETS_UP	65	56		
DELPUECH_FOXO3_TARGETS_DN	40	33		
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	57	44		
KASLER_HDAC7_TARGETS_1_UP	191	147		
KASLER_HDAC7_TARGETS_1_DN	17	15		
KASLER_HDAC7_TARGETS_2_UP	7		Rejected!	
KASLER_HDAC7_TARGETS_2_DN	31	24		
DORMOY_ELAVL1_TARGETS	18		Rejected!	
LEE_BMP2_TARGETS_UP	773		Rejected!	
LEE_BMP2_TARGETS_DN	899		Rejected!	
BILANGES_SERUM_SENSITIVE_GENES	81	54		
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	69	62		
BILANGES_RAPAMYCIN_SENSITIVE_GENES	37	35		
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	70	65		
BILANGES_SERUM_SENSITIVE_VIA_TSC1	21		Rejected!	
BILANGES_SERUM_SENSITIVE_VIA_TSC2	31	28		
BILANGES_SERUM_RESPONSE_TRANSLATION	34	24		
KIM_TIAL1_TARGETS	31	27		
DUAN_PRDM5_TARGETS	78	41		
DALESSIO_TSA_RESPONSE	26		Rejected!	
FEVR_CTNNB1_TARGETS_UP	688		Rejected!	
FEVR_CTNNB1_TARGETS_DN	555		Rejected!	
FARDIN_HYPOXIA_9	7		Rejected!	
FARDIN_HYPOXIA_11	32	29		
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	20		Rejected!	
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	19	16		
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	271	187		
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	322	241		
WINZEN_DEGRADED_VIA_KHSRP	100	66		
VANLOO_SP3_TARGETS_UP	9		Rejected!	
VANLOO_SP3_TARGETS_DN	88	67		
YUAN_ZNF143_PARTNERS	22	21		
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	843		Rejected!	
RAFFEL_VEGFA_TARGETS_UP	9		Rejected!	
RAFFEL_VEGFA_TARGETS_DN	5		Rejected!	
TERAO_AOX4_TARGETS_HG_UP	27	25		
TERAO_AOX4_TARGETS_HG_DN	6		Rejected!	
TERAO_AOX4_TARGETS_SKIN_UP	30	26		
TERAO_AOX4_TARGETS_SKIN_DN	23		Rejected!	
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	77	57		
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	161	117		
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	296	201		
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	403	248		
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	573		Rejected!	
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	1082		Rejected!	
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	43	28		
WACKER_HYPOXIA_TARGETS_OF_VHL	13		Rejected!	
IKEDA_MIR1_TARGETS_UP	54	52		
IKEDA_MIR1_TARGETS_DN	6		Rejected!	
IKEDA_MIR133_TARGETS_UP	44	42		
IKEDA_MIR133_TARGETS_DN	6		Rejected!	
IKEDA_MIR30_TARGETS_UP	116	100		
IKEDA_MIR30_TARGETS_DN	23	16		
KUWANO_RNA_STABILIZED_BY_NO	7		Rejected!	
LIU_TOPBP1_TARGETS	14		Rejected!	
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	26	22		
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN	8		Rejected!	
KATSANOU_ELAVL1_TARGETS_UP	173	106		
KATSANOU_ELAVL1_TARGETS_DN	146	104		
WANG_THOC1_TARGETS_UP	5		Rejected!	
WANG_THOC1_TARGETS_DN	20		Rejected!	
SERVITJA_ISLET_HNF1A_TARGETS_UP	169	105		
SERVITJA_ISLET_HNF1A_TARGETS_DN	107	69		
SERVITJA_LIVER_HNF1A_TARGETS_UP	136	103		
SERVITJA_LIVER_HNF1A_TARGETS_DN	163	86		
MADAN_DPPA4_TARGETS	61	17		
KOHOUTEK_CCNT1_TARGETS	51	40		
KOHOUTEK_CCNT2_TARGETS	56	30		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	46	37		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	20		Rejected!	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	108	70		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5	11		Rejected!	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	29	18		
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	398	302		
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	75	63		
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	149	115		
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	29	25		
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	856		Rejected!	
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	646		Rejected!	
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	144	133		
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP	12		Rejected!	
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN	6		Rejected!	
YANG_BCL3_TARGETS_UP	333	242		
YANG_BCL3_TARGETS_DN	7		Rejected!	
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	35	31		
VERNOCHET_ADIPOGENESIS	19		Rejected!	
IM_SREBF1A_TARGETS	5		Rejected!	
GUO_TARGETS_OF_IRS1_AND_IRS2	96	81		
HUANG_GATA2_TARGETS_UP	150	110		
HUANG_GATA2_TARGETS_DN	72	58		
LE_NEURONAL_DIFFERENTIATION_UP	18		Rejected!	
LE_NEURONAL_DIFFERENTIATION_DN	19	18		
STEINER_ERYTHROCYTE_MEMBRANE_GENES	14		Rejected!	
PLASARI_TGFB1_TARGETS_1HR_UP	33	25		
PLASARI_TGFB1_TARGETS_1HR_DN	5		Rejected!	
PLASARI_TGFB1_TARGETS_10HR_UP	195	137		
PLASARI_TGFB1_TARGETS_10HR_DN	255	159		
PLASARI_NFIC_TARGETS_BASAL_UP	28		Rejected!	
PLASARI_NFIC_TARGETS_BASAL_DN	22	15		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	33	22		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	107	75		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	58	43		
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	31	18		
WANG_MLL_TARGETS	293	150		
SANDERSON_PPARA_TARGETS	15		Rejected!	
KANG_GLIS3_TARGETS	36		Rejected!	
DELACROIX_RARG_BOUND_MEF	367	294		
DELACROIX_RAR_TARGETS_UP	47	38		
DELACROIX_RAR_TARGETS_DN	25	17		
DELACROIX_RAR_BOUND_ES	466	341		
KRIEG_HYPOXIA_VIA_KDM3A	53	41		
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	200	166		
KRIEG_HYPOXIA_NOT_VIA_KDM3A	746		Rejected!	
MALIK_REPRESSED_BY_ESTROGEN	13		Rejected!	
TIAN_BHLHA15_TARGETS	16		Rejected!	
LIU_IL13_MEMORY_MODEL_UP	17		Rejected!	
LIU_IL13_MEMORY_MODEL_DN	5		Rejected!	
LIU_IL13_PRIMING_MODEL	15		Rejected!	
ALFANO_MYC_TARGETS	239	204		
FU_INTERACT_WITH_ALKBH8	13		Rejected!	
SUZUKI_CTCFL_TARGETS_UP	12		Rejected!	
REICHERT_MITOSIS_LIN9_TARGETS	27	27		
GUILLAUMOND_KLF10_TARGETS_UP	49	33		
GUILLAUMOND_KLF10_TARGETS_DN	30	21		
FORTSCHEGGER_PHF8_TARGETS_UP	278	195		
FORTSCHEGGER_PHF8_TARGETS_DN	783		Rejected!	
BRIDEAU_IMPRINTED_GENES	65	33		
PEDRIOLI_MIR31_TARGETS_UP	223	95		
PEDRIOLI_MIR31_TARGETS_DN	412	223		
PHONG_TNF_TARGETS_UP	63	52		
PHONG_TNF_TARGETS_DN	8		Rejected!	
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	225	198		
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	164	138		
PHONG_TNF_RESPONSE_NOT_VIA_P38	341	276		
RATTENBACHER_BOUND_BY_CELF1	438	266		
KINNEY_DNMT1_METHYLATION_TARGETS	13		Rejected!	
ABDELMOHSEN_ELAVL4_TARGETS	16		Rejected!	
ZHANG_ADIPOGENESIS_BY_BMP7	14		Rejected!	
FOSTER_KDM1A_TARGETS_UP	265	112		
FOSTER_KDM1A_TARGETS_DN	202	174		
YU_BAP1_TARGETS	29	26		
RAO_BOUND_BY_SALL4_ISOFORM_A	186	103		
RAO_BOUND_BY_SALL4_ISOFORM_B	522	372		
RAO_BOUND_BY_SALL4	229	162		
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	218	196		
BOUDOUKHA_BOUND_BY_IGF2BP2	106	93		
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	150	94		
BOSCO_TH1_CYTOTOXIC_MODULE	114	52		
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	78	57		
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	69	43		
PECE_MAMMARY_STEM_CELL_UP	138	117		
PECE_MAMMARY_STEM_CELL_DN	143	113		
ABRAMSON_INTERACT_WITH_AIRE	44	40		
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	12		Rejected!	
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	274	150		
KUMAR_AUTOPHAGY_NETWORK	72	38		
GENTLES_LEUKEMIC_STEM_CELL_UP	29	16		
GENTLES_LEUKEMIC_STEM_CELL_DN	19		Rejected!	
ROESSLER_LIVER_CANCER_METASTASIS_UP	106	83		
ROESSLER_LIVER_CANCER_METASTASIS_DN	51	42		
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	22	21		
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN	12		Rejected!	
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	39	28		
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN	16		Rejected!	
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	28	23		
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN	15		Rejected!	
HOLLEMAN_DAUNORUBICIN_B_ALL_UP	10		Rejected!	
HOLLEMAN_DAUNORUBICIN_B_ALL_DN	12		Rejected!	
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	20	18		
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN	11		Rejected!	
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	27	20		
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	20	16		
HOLLEMAN_DAUNORUBICIN_ALL_UP	7		Rejected!	
HOLLEMAN_DAUNORUBICIN_ALL_DN	8		Rejected!	
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	23		Rejected!	
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	26	24		
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	125	92		
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	64	40		
LIM_MAMMARY_STEM_CELL_UP	481	285		
LIM_MAMMARY_STEM_CELL_DN	416	372		
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	58	32		
LIM_MAMMARY_LUMINAL_PROGENITOR_DN	14		Rejected!	
LIM_MAMMARY_LUMINAL_MATURE_UP	111	83		
LIM_MAMMARY_LUMINAL_MATURE_DN	95	71		
DURAND_STROMA_S_UP	299	184		
DURAND_STROMA_NS_UP	168	121		
SMIRNOV_RESPONSE_TO_IR_2HR_UP	53	46		
SMIRNOV_RESPONSE_TO_IR_2HR_DN	57	42		
SMIRNOV_RESPONSE_TO_IR_6HR_UP	168	127		
SMIRNOV_RESPONSE_TO_IR_6HR_DN	114	87		
GHANDHI_DIRECT_IRRADIATION_UP	104	59		
GHANDHI_DIRECT_IRRADIATION_DN	35	20		
GHANDHI_BYSTANDER_IRRADIATION_UP	84	49		
GHANDHI_BYSTANDER_IRRADIATION_DN	12		Rejected!	
WARTERS_RESPONSE_TO_IR_SKIN	82	48		
WARTERS_IR_RESPONSE_5GY	50	35		
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR	8		Rejected!	
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	84	80		
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	126	119		
ZWANG_EGF_PERSISTENTLY_UP	34	22		
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	548	363		
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	54	32		
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	232	178		
ZWANG_DOWN_BY_2ND_EGF_PULSE	317	125		
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	1932	495		
ZWANG_EGF_INTERVAL_UP	110	36		
ZWANG_EGF_INTERVAL_DN	237	158		
ZWANG_EGF_PERSISTENTLY_DN	63	44		
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	20		Rejected!	
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	5		Rejected!	
HORTON_SREBF_TARGETS	24	24		
HECKER_IFNB1_TARGETS	95	54		
FARMER_BREAST_CANCER_CLUSTER_6	14		Rejected!	
FARMER_BREAST_CANCER_CLUSTER_5	19	17		
FARMER_BREAST_CANCER_CLUSTER_4	19	16		
FARMER_BREAST_CANCER_CLUSTER_3	16		Rejected!	
EPPERT_LSC_R	41	31		
EPPERT_HSC_R	126	83		
EPPERT_PROGENITOR	138	125		
EPPERT_CE_HSC_LSC	41	21		
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	83	69		
MACAEVA_PBMC_RESPONSE_TO_IR	106	74		
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	311	241		
FISCHER_G1_S_CELL_CYCLE	200	149		
FISCHER_G2_M_CELL_CYCLE	236	215		
FISCHER_DREAM_TARGETS	968		Rejected!	
GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	1009		Rejected!	
GRYDER_PAX3FOXO1_TOP_ENHANCERS	441	365		
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	438	334		
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	175	136		
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1	63	34		
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	345	272		
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN	274	199		
VILLANUEVA_LIVER_CANCER_KRT19_UP	175	146		
VILLANUEVA_LIVER_CANCER_KRT19_DN	63	41		
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP	14		Rejected!	
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN	21		Rejected!	
ANDERSEN_LIVER_CANCER_KRT19_UP	35	33		
ANDERSEN_LIVER_CANCER_KRT19_DN	75	50		
KIM_LIVER_CANCER_POOR_SURVIVAL_UP	22	21		
KIM_LIVER_CANCER_POOR_SURVIVAL_DN	43	23		
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR	17		Rejected!	
HOLLERN_EMT_BREAST_TUMOR_UP	140	99		
HOLLERN_EMT_BREAST_TUMOR_DN	123	108		
HOLLERN_SQUAMOUS_BREAST_TUMOR	167	91		
HOLLERN_PAPILLARY_BREAST_TUMOR	19		Rejected!	
HOLLERN_MICROACINAR_BREAST_TUMOR_UP	46	37		
HOLLERN_MICROACINAR_BREAST_TUMOR_DN	15		Rejected!	
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP	11		Rejected!	
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN	30	22		
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	190	158		
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	383	127		
FLORIO_HUMAN_NEOCORTEX	46		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN	34	22		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN	11		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP	16		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN	11		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN	15		Rejected!	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP	17	16		
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN	8		Rejected!	
CASTELLANO_HRAS_TARGETS_UP	5		Rejected!	
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN	5		Rejected!	
BIERIE_INFLAMMATORY_RESPONSE_TGFB1	5		Rejected!	
NICK_RESPONSE_TO_PROC_TREATMENT_UP	5		Rejected!	
MALTA_CURATED_STEMNESS_MARKERS	21		Rejected!	
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	159	75		
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	155	123		
DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	22	16		
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	242	217		
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN	401	258		
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP	176	131		
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP	394	291		
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN	306	221		
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP	472	242		
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN	372	190		
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP	143	95		
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN	210	94		
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	128	80		
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN	162	73		
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP	179	110		
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN	227	100		
MEBARKI_HCC_PROGENITOR_WNT_UP	199	110		
MEBARKI_HCC_PROGENITOR_WNT_DN	93	36		
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	88	51		
MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT	31		Rejected!	
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT	24		Rejected!	
MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT	17		Rejected!	
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD	125	71		
MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD	71	25		
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD	47	28		
MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD	22		Rejected!	
MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	585	392		
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN	461	192		
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	148	92		
